[go: up one dir, main page]

US20070031857A1 - Compositions and methods for processing and amplification of DNA, including using multiple enzymes in a single reaction - Google Patents

Compositions and methods for processing and amplification of DNA, including using multiple enzymes in a single reaction Download PDF

Info

Publication number
US20070031857A1
US20070031857A1 US11/366,222 US36622206A US2007031857A1 US 20070031857 A1 US20070031857 A1 US 20070031857A1 US 36622206 A US36622206 A US 36622206A US 2007031857 A1 US2007031857 A1 US 2007031857A1
Authority
US
United States
Prior art keywords
dna
oligonucleotide
stem
loop
endonuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/366,222
Other languages
English (en)
Inventor
Vladimir Makarov
Emmanuel Kamberov
Brendan Tarrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Bio USA Inc
Original Assignee
Rubicon Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11/366,222 priority Critical patent/US20070031857A1/en
Application filed by Rubicon Genomics Inc filed Critical Rubicon Genomics Inc
Assigned to RUBICON GENOMICS, INC. reassignment RUBICON GENOMICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KAMBEROV, EMMANUEL, MAKAROV, VLADIMIR L., TARRIER, BRENDAN J.
Publication of US20070031857A1 publication Critical patent/US20070031857A1/en
Priority to US12/270,850 priority patent/US7803550B2/en
Priority to US12/892,359 priority patent/US8071312B2/en
Priority to US13/286,937 priority patent/US8399199B2/en
Priority to US13/766,607 priority patent/US8728737B2/en
Priority to US14/250,538 priority patent/US9598727B2/en
Priority to US15/430,803 priority patent/US10196686B2/en
Priority to US15/674,468 priority patent/US10208337B2/en
Assigned to TAKARA BIO USA, INC. reassignment TAKARA BIO USA, INC. MERGER (SEE DOCUMENT FOR DETAILS). Assignors: RUBICON GENOMICS, INC.
Priority to US16/231,002 priority patent/US11072823B2/en
Priority to US17/326,844 priority patent/US20210292828A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1068—Template (nucleic acid) mediated chemical library synthesis, e.g. chemical and enzymatical DNA-templated organic molecule synthesis, libraries prepared by non ribosomal polypeptide synthesis [NRPS], DNA/RNA-polymerase mediated polypeptide synthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Definitions

  • the present invention generally concerns the fields of molecular biology and cellular biology.
  • the present invention regards preparation and amplification of molecules, optionally utilizing a novel single-step reaction.
  • Enzymatic reactions that involve DNA and RNA are numerous, and they play a central role in maintenance and propagation of living cells. Since the discovery of the DNA double helix structure in 1953, researchers have found, isolated and introduced into practice a multitude of different enzymes that can, for example, cut, nick, trim, join, unwind, phosphorylate, de-phosphorylate, methylate, de-methylate, recombine, replicate, transcribe, repair, and perform many other reactions with nucleic acid molecules. These enzymes are now actively used in many areas of biology, biotechnology and medicine to clone, amplify, sequence, identify mutations, quantify gene copy number, establish expression patterns, determine DNA methylation status, etc.
  • DNA analysis involves multiple enzymatic reactions that are performed in a sequential manner, with intermediate purification steps between the reactions.
  • the reactions are multiplexed to combine in one reaction the analysis of several DNA or RNA targets, and the nucleic acid processing or analysis may involve multiplexing of two or three enzymatic processes in one reaction.
  • DNA and RNA enzymatic reactions frequently utilize synthetic nucleic acid components, such as single stranded or double stranded oligonucleotides that function as PCR or sequencing primers, ligation adaptors, or fluorescent probes, for example.
  • an adaptor or linker is used in many areas of molecular biology.
  • the usefulness of adapted DNA molecules is illustrated by but not limited to several examples, such as ligation-mediated locus-specific PCR, ligation-mediated whole genome amplification, adaptor-mediated DNA cloning, DNA affinity tagging, DNA labeling, etc.
  • the adaptor can be ligated to the 5′ end, the 3′ end, or both strands of DNA.
  • the adaptor can have a 3′ or 5′ overhang, depending on the structure of the overhang generated by restriction enzyme digestion of DNA. It can also a have blunt end, especially in the cases when DNA ends are “polished” after enzymatic, mechanical, or chemical DNA fragmentation.
  • Ligation-mediated PCR amplification is achieved by using a locus-specific primer (or several nested primers) and a universal primer complementary to the adaptor sequence.
  • the adaptor can be ligated to both strands of DNA or only to the 3′ end followed by extension.
  • the adaptor can have a 3′ or 5′ overhang, depending on the structure of the DNA end generated by restriction enzyme or other enzyme used to digest DNA.
  • RNA molecules can also have a blunt end, such as in the cases where DNA ends after enzymatic DNA cleavage are blunt or when the ends are repaired and “polished” after enzymatic, mechanical, or chemical DNA fragmentation.
  • Whole genome PCR amplification is achieved by using one or two universal primers complementary to the adaptor sequence(s), in specific embodiments.
  • Adaptors are frequently used for DNA cloning (see Sambrook et al., 1989, for example). Ligation of double stranded adaptors to DNA fragments produced by sonication, nebulization, or hydro-shearing process followed by restriction digestion within the adaptors allows production of DNA fragments with 3′ or 5′ protruding ends that can be efficiently introduced into a vector sequence and cloned.
  • Stem-loop (also referred to as hairpin) oligonucleotides have been used in several applications for analysis and detection of nucleic acids. These applications include molecular beacons, stem-loop PCR primers, and stem-loop DNA probes, immobilized on microarrays (Broude, 2002).
  • a molecular beacon is a single-stranded oligonucleotide probe containing a sequence complementary to the target that is flanked by self-complementary termini, and carries a fluorophore and a quencher at the 3′ and 5′ ends, respectively (Tyagi and Kramer, 1996). In the absence of target the fluorophore and the quencher are in a close proximity, which quenches fluorescence. Upon hybridization with the target, the beacon changes its conformation so that the fluorophore and the quencher become separated, and fluorescence increases up to 100-200 times.
  • Molecular beacons have found many applications for real-time monitoring of PCR (Tyagi et al., 1998) and isothermal amplification (de Baar et al., 2001), as microarray-immobilized probes (Liu et al., 2000), as antisense probes for RNA detection in vivo (Sokol et al., 1998), and as a probe to measure DNA polymerase activity (Summerer and Marx, 2002) and monitor conformational changes of DNA targets (Goddard et al., 2000).
  • PCR primers containing hairpin structures on their 5′ ends with donor and acceptor moieties located in close proximity on the stem-loop stem have been proposed for homogeneous (a closed tube) format for amplification, real-time quantification and mismatch detection by PCR (Broude, 2002).
  • a stem-loop primer with a fluorophore at the 5′ end and a “scorpion” probe is simultaneously a molecular beacon and a PCR primer (Whitcombe et al., 1999). It has a tail attached to its 5′ end by a linker that prevents copying of the 5′ extension.
  • the probe element is designed so that it hybridizes to its target only when the target site has been incorporated into the same molecule by extension of the tailed primer. It was also shown that stem-loop probes can be used as primers for PCR to reduce primer-dimer formation and mispriming, thereby increasing its specificity (Kaboev et al., 2000).
  • Stem-loop probes can also be used as capture devices if the loop is immobilized on a surface and dangling ends are used for stacking-hybridization, thus providing both faster kinetics and higher hybrid stability (Riccelli et al., 2001).
  • Immobilized molecular beacon probes can be used for direct detection of non-amplified target DNA and RNA molecules (Hamad-Schifferli et al. 2002).
  • multiplexed reactions that involve DNA or RNA are described to date.
  • the multiplexed reactions can be divided into two major categories: reactions where two or more DNA/RNA sequences are amplified or detected simultaneously in one enzymatic process, and reactions where several enzymatic processes occur simultaneously with one DNA or RNA template.
  • Multiplex PCR and RT-PCR are examples of the first category of multiplexed reactions (Mackay et al., 2000). In this case, several genomic or cDNA regions are amplified in one polymerase chain reaction carried out by one thermostable DNA polymerase. Whole genome or whole transcriptome amplification is another example of highly multiplexed DNA/RNA amplification reactions carried out by methophilic (Phi 29) or thermophylic (Taq) DNA polymerase (Sambrook et al., 1989).
  • RNA polymerase a DNA polymerase and a restriction endonuclease
  • SDA DNA strand-displacement amplification
  • TMA and NASBA methods utilize transcription-mediated amplification that involves three enzymes: T7 RNA polymerase, reverse transcriptase, and RNase H (Deiman et al., 2001).
  • SDA two enzymes (a DNA polymerase and a restriction endonuclease) are combined in one enzymatic step to amplify DNA (Hellyer and Naolean, 2004).
  • DNA nick-translation method is an example of a DNA labeling reaction that involves two enzymes. The method is based on simultaneous incubation of DNA with DNase I and DNA polymerase I. DNase I generates nicks in the DNA molecule, while DNA polymerase I incorporates labeled nucleotides by initiating DNA synthesis from the nicked sites (Sambrook
  • dU-glycosylase which is also referred to as Uracyl-DNA Glycosylase or UDG
  • UDG Uracyl-DNA Glycosylase
  • endonuclease VIII can be combined to produce the enzymatic mix, or the USER enzyme for fragmentation of DNA containing dU bases (New England Biolabs; Beverly, Mass.) may be employed. The fragmentation process occurs through enzymatic generation and cleavage of abasic sites at positions of dU bases.
  • the present invention overcomes deficiencies in the art by providing novel methods and compositions for amplification of a plurality of double stranded DNA molecules by incorporating at least one sequence onto the ends of the DNA molecules.
  • the invention avoids the disadvantages of other methods, such as the generation of primer dimers in polymerase chain reaction, for example.
  • the present invention allows for the amplification of molecules having at least one double stranded region by using adaptors that avoid the limitations of some adaptor molecules, such as those having the propensity to form adaptor dimers.
  • the present invention provides an inert oligonucleotide for attachment to a double stranded molecule such that it renders the oligonucleotide-ligated molecule capable of being modified, such as amplified, for example by polymerase chain reaction.
  • the attached oligonucleotide becomes active and suitable for providing at least in part one or more sequences employable for amplification, while the non-attached, free adaptor remains inactive.
  • the free, non-attached inert adaptor can neither be primed nor used as a PCR primer (until it is intentionally and specifically fragmented and converted into a PCR primer); during amplification by transcription the promoter sequence of the non-attached, free adaptor does not initiate RNA synthesis; during amplification by strand displacement, the nicking enzyme recognition sequence of the non-attached adaptor remains uncut.
  • the inert adaptor comprises a stem-loop oligonucleotide, wherein the inertness of the stem-loop oligonucleotide is at least in part a result of the dormant nature of its unique structure, biochemical properties (one enzymatically active end), and, or physico-chemical characteristics (extremely high thermostability, for example).
  • the oligonucleotide may comprise RNA, DNA, or both.
  • the oligonucleotide may have one or more hairpins, and it may be further described as comprising any structure with multiple secondary structure and only one end.
  • the oligonucleotide can change its functionality upon attachment to a double stranded nucleic acid molecule (DNA, RNA, or both).
  • a conformational change of the oligonucleotide upon such as following, for example
  • one or more functional properties of the oligonucleotide become altered, such as one or more functional properties hidden in the oligonucleotide prior to attachment manifesting upon attachment.
  • the invention further provides novel conditions for modification of DNA molecules with the adaptors, and subsequent amplification.
  • the process of DNA analysis involves multiple enzymatic reactions that are performed in a sequential manner, frequently with intermediate purification steps between at least some of the reactions.
  • preparation of DNA libraries for subsequent amplification and analysis involves ligation of adaptor sequences to DNA ends to introduce a priming site for the PCR-mediated whole genome amplification and ligation-mediated PCR, a promoter element for the transcription-mediated DNA amplification, and or cohesive ends to facilitate DNA integration into a vector molecule for cloning.
  • Preparation of library from genomic or viral DNA by current adaptor attachment procedures typically occur in 6 steps ( FIG. 1A ):
  • Step 1 fragmentation of high molecular weight (HMW) DNA to a size amenable to amplification or cloning
  • Step 2 DNA purification to remove nucleases and other reagents
  • Step 3 “polishing” of DNA ends by a 3 proofreading DNA polymerase(s) to generate blunt-ended DNA fragments with the 3′ hydroxyl and 5′ phosphate groups at the termini;
  • Step 4 DNA purification to remove the polymerase and replace the buffer, or, alternatively, heat inactivation of the DNA polymerase;
  • Step 5 adaptor ligation
  • Step 6 3′ end extension (in the case when an adaptor is ligated only to one strand of DNA, specifically to the 5′ phosphate).
  • the present invention satisfies a long-felt need in the art for obviating the requirement for multiple manipulations for nucleic acid processing.
  • the current invention introduces and demonstrates new methods and compositions that allow reduction of several important multi-step enzymatic DNA processes to a single-step-reaction that is performed in one reaction volume ( FIGS. 1B and 1C ).
  • Such simplification has been achieved by developing a highly multiplexed enzymatic method (Enz-O-Mix) that combines a substantial number (from 2 to 10) of enzymatic processes into one complex reaction mixture that occurs under universal buffer conditions.
  • the current invention introduces novel processes of DNA library preparation and/or DNA amplification ( FIG. 1C ) that reduce the whole multi-step process to a single-step multiplexed enzymatic reaction involving as a minimum two Enzymes, a stem-loop (hairpin) Oligonucleotide with a special base/bonds composition, and a universal buffer (Mix), which is herein referred to as Enz-O-Mix, that supports efficient functioning of all enzymatic activities present in the mixture.
  • FIG. 1C novel processes of DNA library preparation and/or DNA amplification
  • the invention demonstrates that the Enz-O-Mix approach can be used to prepare a DNA library for whole genome amplification (WGA Library), a Methylome library for amplification and analysis of methylated DNA regions, and/or even directly amplify DNA in a single multi-enzyme reaction, for example.
  • the Enz-O-Mix library/amplification has no limitations on the size and nature of DNA in the reaction.
  • the method can be applied to high molecular weight DNA, such as is isolated from tissues or cell culture, for example, as well as highly degraded DNA, such as cell-free DNA from blood and urine and/or DNA extracted from formalin-fixed, paraffin-embedded tissues, for example.
  • the applications of the Enz-O-Mix method are numerous.
  • the Enz-O-Mix method is easy to automate and use in clinical diagnostic and point-of-care applications, for example.
  • different enzyme combinations are utilized for many novel kits and assays and utilized in such areas as biotechnology, the pharmaceutical industry, molecular diagnostics, forensics, pathology, bio-defense, and/or bio-computing, for example.
  • the Enz-O-Mix approach is a simple and cost-effective alternative to the “lab-on-a chip” microfluidic approach that is currently attempting to solve the same problem (multi-step DNA processing) by reduction of reaction volumes and integration of multiple reactions into a small format ( FIG. 2 ).
  • the method can be used for in vitro as well as for in vivo nucleic acid amplification and/or detection.
  • the present invention introduces a concept of multiplexing two or more enzymatic processes in one reaction, teaches how to optimize a highly multiplexed enzymatic process, and demonstrates in multiple specific examples the efficacy of this approach.
  • the present invention is directed to compositions and methods for simultaneous processing of DNA molecules with a combination of enzymes in a one-step-one-tube reaction and producing either a collection of molecules suitable for amplification, or amplified DNA molecules.
  • the present invention greatly reduces the number of steps for library preparation by consolidating a series of steps into one step.
  • these protocols greatly reduce the number of steps for library syntheses that utilize adaptors. That is, in the case of WGA library preparation from high molecular weight DNA, for example, the number of steps is reduced from about 6 to 1 ( FIGS. 1A and 1B ). In the case of WMA library preparation from high molecular weight DNA, for example, the number of steps is reduced from about 7 to 1. In the case of WGA library preparation from fragmented DNA (plasma, serum, or urine, for example), the number of steps is reduced from about 4 to 1 ( FIG. 1B ). In the case of Methylome library preparation from fragmented DNA, for example, the number of steps is reduced from about 5 to 1 ( FIG. 1B ).
  • the methods of the invention can be easily applied to any type of fragmented double stranded DNA including but not limited to, for example, free DNA isolated from plasma, serum, and/or urine; apoptotic DNA from cells and/or tissues; DNA fragmented enzymatically in vitro (for example, by DNase I and/or restriction endonuclease); and/or DNA fragmented by mechanical forces (hydro-shear, sonication, nebulization, etc.).
  • the invention can be easily applied to any high molecular weight double stranded DNA including, for example, DNA isolated from tissues, cell culture, bodily fluids, animal tissue, plant, bacteria, fungi, viruses, etc.
  • an enzymatic mixture comprising from about 2 to about 18 different enzymes in one buffer and a stem-loop (hairpin) oligonucleotide with a specific base/bonds composition.
  • a one-step enzymatic process including one or more of the following: a) “polishing” of DNA and stem-loop oligonucleotide ends by Klenow fragment of DNA polymerase I (or other proofreading DNA polymerase); b) ligation of the 3′ end of stem-loop oligonucleotide to the 5′ end of DNA, such as by a ligase, for example, by T4 DNA ligase; c) “fill-in” DNA synthesis that is initiated at the 3′ end of DNA, propagates towards the end of the stem-loop oligonucleotide, and stops at a replication block or at the end of the oligonucleotide; and d) cleavage in the middle of a generated inverted repeat by a restriction nuclease; and e) restriction cleavage with a mixture of methylation-sensitive restriction enzymes or methylation-specific nuclease(s) (such as in embodiment
  • an inverted repeat (palindrome) at the end of DNA molecules is not generated (or is generated and removed), because it may inhibit the amplification step (PCR), priming of the cDNA strand synthesis (amplification by transcription), or priming of the second DNA strand synthesis (amplification by strand displacement DNA synthesis).
  • PCR amplification step
  • priming of the cDNA strand synthesis amplification by transcription
  • priming of the second DNA strand synthesis amplification by strand displacement DNA synthesis
  • a chemical modification such as hexaethylene glycol (HEG) linker, a bulky base analog, or one or several abasic sites within the loop or adjacent to it, can be introduced during oligonucleotide synthesis. Such modifications will terminate the replication within the stem-loop oligonucleotide.
  • HOG hexaethylene glycol
  • the replication block is generated during the reaction by incorporating one or more dU bases into the stem-loop oligonucleotide design and including dU-glycosylase (which is also referred to as Uracyl-DNA Glycosylase or UDG) in the reaction mix.
  • dU-glycosylase which is also referred to as Uracyl-DNA Glycosylase or UDG
  • a specific site for a cleavage enzyme is generated during “fill-in” DNA synthesis that is initiated at the 3′ end of the DNA, propagates towards the end of the stem-loop oligonucleotide, and stops at the 5′ end of the oligonucleotide.
  • Such a site resides originally either completely or partially within the single-stranded loop of an oligonucleotide and becomes functional (cleavable) only after conversion of this loop into double-stranded form.
  • a cleavage enzyme is represented by a restriction endonuclease, in another by a homing endonuclease.
  • the methods further comprise simultaneous digestion with an endonuclease or combination of endonucleases, such as restriction endonucleases, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonucleases, etc., to generate in one step Whole Genome or Whole Methylome library even from high molecular weight (HMW) DNA.
  • endonuclease or combination of endonucleases such as restriction endonucleases, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonucleases, etc.
  • a library generated by a one-step process is further amplified by PCR using universal primer complementary to the sequence introduced by attachment of a stem-loop oligonucleotide.
  • library generation and PCR amplification are combined into one integrated, closed-tube process in a thermocycler.
  • an integrated, closed-tube library preparation/amplification process is supported by a universal PCR primer included in the original Enz-O-Mix.
  • an integrated, closed-tube library preparation/amplification process is supported by a stem-loop oligonucleotide converted into a functional universal primer as a result of enzymatic and chemical reactions that occur before PCR amplification.
  • degradable stem-loop oligonucleotides are used as locus-specific primers for a hot start PCR process.
  • a library generated by one-step process is further amplified by transcription utilizing a promoter sequence (T7, T3, SP6, etc.) introduced by attachment of a stem-loop oligonucleotide.
  • a promoter sequence T7, T3, SP6, etc.
  • a stem-loop oligonucleotide design is employed for the one-step library synthesis reaction, although in alternative embodiments other adaptors may be utilized, such as a standard linear two-oligonucleotide adaptor, for example.
  • a stem-loop oligonucleotide provides a synthesized library with a new function that was present neither in the DNA molecule nor in the stem-loop oligonucleotide prior to its attachment.
  • Examples include a functionally inactive T7 promoter sequence, a non-cleavable restriction site, and/or inactive nicking site residing at least partially within the loop or stem region of the stem-loop oligonucleotide and activated only by the attachment process and conversion of the single stranded loop into a double stranded molecule.
  • a stem-loop oligonucleotide provides a synthesized library with a 5′ overhang that was not present either in the DNA molecule or in the stem-loop oligonucleotide prior to its attachment, and that can be used for covalent or non-covalent immobilization of a synthesized library on a solid support via hybridization or hybridization and ligation to a covalently attached oligonucleotide.
  • the library synthesis and its immobilization within the tube (well) occurs simultaneously in a one Enz-O-Mix process.
  • combinations of enzymes and stem-loop oligonucleotides are mixed together in a special tube with a covalently attached capture oligonucleotide to produce Enz-O-Mix-Immobilization kits for high throughput DNA processing and diagnostic applications in solid phase format.
  • combinations of enzymes and stem-loop oligonucleotides are mixed together to produce Enz-O-Mix kits for high throughput DNA processing and diagnostic applications.
  • combinations of enzymes and stem-loop oligonucleotides are mixed together to produce integrated, closed-tube Enz-O-Mix kits for high throughput DNA fragmentation, amplification and labeling.
  • the present invention is directed to a system and method for preparing a collection of molecules, particularly molecules suitable for amplification, such as amplification utilizing known sequences on the molecules.
  • the oligonucleotide comprises a known sequence.
  • kit housed in a suitable container that comprises one or more compositions of the invention and/or comprises one or more compositions suitable for at least one method of the invention.
  • a method of preparing a nucleic acid molecule comprising: providing a double stranded nucleic acid molecule; and attaching one strand of a stem-loop oligonucleotide comprising an inverted repeat and a loop to the double stranded nucleic acid molecule to produce an oligonucleotide-attached nucleic acid molecule.
  • the double stranded nucleic acid molecule may be a double stranded DNA molecule, in some embodiments.
  • the attaching is further defined as attaching the oligonucleotide to the double stranded nucleic acid molecule under conditions to produce a non-covalent junction, such as a nick, a gap, or a 5′ flap structure, in the oligonucleotide-attached nucleic acid molecule.
  • the attaching is further defined as ligating.
  • the method may further comprise displacing one strand of the oligonucleotide from the oligonucleotide-attached nucleic acid molecule by strand displacement or by nick translation polymerization.
  • At least part of the oligonucleotide-attached nucleic acid molecule is amplified, such as by polymerase chain reaction, RNA transcription, or strand displacement, for example.
  • Methods of the invention may further comprise amplifying an oligonucleotide-attached nucleic acid molecule, wherein at least part of the inverted repeat is excluded from the amplified oligonucleotide-attached nucleic acid molecule.
  • Ligating embodiments may be further defined as comprising: generating ligatable ends on the double stranded nucleic acid molecule; generating a ligatable end on the stem-loop oligonucleotide; and ligating one strand of the ligatable end of the stem-loop oligonucleotide to one strand of an end of the nucleic acid molecule, thereby generating a non-covalent junction, such as a nick, a gap, or a 5′ flap structure, in the oligonucleotide-attached nucleic acid molecule.
  • the methods comprise generating blunt ends on the nucleic acid molecule; generating a blunt end on the stem-loop oligonucleotide; and ligating one strand of the blunt end of the stem-loop oligonucleotide to one strand of a blunt end of the nucleic acid molecule, thereby generating a nick in the oligonucleotide-ligated nucleic acid molecule.
  • the stem-loop oligonucleotide comprises a known sequence, for example a regulatory sequence, including a RNA polymerase promoter sequence.
  • a regulatory sequence may reside at least in part within the stem of the stem-loop oligonucleotide, within the loop of the stem-loop oligonucleotide, or both.
  • Methods of the invention may further comprise digesting the DNA molecule with one or more endonucleases to produce DNA fragments; producing blunt ends on the DNA fragments; producing a blunt end on the stem-loop oligonucleotide; and ligating one strand of the blunt end of a stem-loop oligonucleotide to one strand of a blunt end of a DNA fragment, thereby generating a nick in an oligonucleotide-ligated DNA fragment.
  • the endonuclease is a restriction endonuclease, DNAse I, or an apoptotic endonuclease, or a mixture thereof.
  • the restriction endonuclease is methylation-specific or methylation-sensitive.
  • the oligonucleotide-attached nucleic acid molecule comprises a nick having a 3′ hydroxy group, wherein there is polymerization from the 3′ hydroxy group of at least part of the oligonucleotide-attached nucleic acid molecule.
  • Strand displacement or nick translation polymerization may be further defined as polymerization that ceases at a non-replicable base or region in the loop or in a region of the stem adjacent to the loop.
  • the method further comprises the step of digesting the double stranded DNA molecule with an endonuclease to generate DNA fragments, wherein the oligonucleotide becomes ligated to one strand of the DNA fragment and wherein polymerization of an oligonucleotide-ligated DNA fragment excludes at least part of the inverted repeat by subjecting the oligonucleotide-ligated DNA fragment to strand displacement or nick translation polymerization that halts at a base or sequence in the loop or in a region of the stem adjacent to the loop.
  • the stem-loop oligonucleotide is further defined as comprising a non-replicable base or sequence.
  • a non-replicable base or sequence in some cases at least part of the non-replicable base or sequence is present in the loop of the oligonucleotide or in a sequence of the stem adjacent to the loop.
  • the non-replicable base or sequence may comprise an abasic site or sequence, hexaethylene glycol, and/or a bulky chemical moiety attached to the sugar-phosphate backbone or the base.
  • the abasic site or sequence is introduced by one or more enzymes in the single solution.
  • the loop of the stem-loop oligonucleotide comprises at least one deoxy-uridine.
  • strand displacement or nick translation polymerization of the oligonucleotide-attached nucleic acid molecule generates an endonuclease site.
  • the methods further comprise the step of digesting the double stranded DNA molecule with an endonuclease to generate DNA fragments, wherein the oligonucleotide becomes blunt end ligated to one strand of the DNA fragment to produce an oligonucleotide-ligated DNA fragment, and wherein strand displacement or nick translation polymerization of the oligonucleotide-ligated DNA fragment generates an endonuclease site.
  • the endonuclease site is a site-specific restriction endonuclease site and at least part of the inverted repeat is removed by cleavage with said restriction endonuclease.
  • the endonuclease site may reside within the stem and/or loop regions. Examples of endonucleases include Eco NI or PacI.
  • the endonuclease site may be a homing endonuclease site, such as I-Ceu I, I-Sce I, Pl-Psp 1, or Pl-Sce I.
  • RNA transcription is initiated from the regulatory sequence, thereby producing at least one transcribed polynucleotide.
  • a regulatory sequence resides at least in part within the stem of the stem-loop oligonucleotide, or at least in part within the loop of the stem-loop oligonucleotide.
  • the regulatory sequence comprises a bacteriophage regulatory sequence, such as a T7 regulatory sequence, a T3 regulatory sequence, or a Sp6 regulatory sequence, for example.
  • a transcribed polynucleotide is replicated by a reverse transcriptase, which may be initiated by hybridization of the oligonucleotide complementary to the 3′ end of the transcribed polynucleotide.
  • the stem-loop oligonucleotide may further comprise a recognition sequence for a nicking endonuclease and the oligonucleotide-attached nucleic acid molecule is amplified by strand displacement synthesis and second strand synthesis, in particular aspects of the invention.
  • the recognition sequence for a nicking endonuclease resides at least in part within the stem of the stem-loop oligonucleotide.
  • the recognition sequence for a nicking endonuclease may reside at least in part within the loop of the stem-loop oligonucleotide.
  • the nicking endonuclease is N.Alw I, N.Bbv CIA, N.Bbv CIB, Nb.Bpu10I, Nb.BsmI, N.BstNBI, or N.Bst 9I.
  • a 5′ end of the stem-loop oligonucleotide lacks a phosphate
  • the oligonucleotide-attached nucleic acid molecule is further modified, such as by cloning, including by incorporation of the modified molecule into a vector, said incorporation occurring at ends in the modified molecule generated by endonuclease cleavage within the inverted repeat.
  • methods of the invention occur in a single suitable solution, wherein the process occurs in the absence of exogenous manipulation.
  • the method may occur at one temperature, such as from about 10° C. to about 75° C.
  • the solution comprises one or more of the following: ligase; DNA polymerase; one or more endonucleases; RNA polymerase; reverse transcriptase; RNase H; deoxy-uridine glycosylase (which is also referred to as Uracyl-DNA Glycosylase or UDG); nickase; thermophilic DNA polymerase; ATP; rNTPs; and dNTPs.
  • a kit housed in a suitable container, comprising: a stem-loop oligonucleotide; and a solution suitable for ligation of the oligonucleotide onto a double stranded molecule; and, optionally, one or more of the following: ligase; DNA polymerase one or more restriction enzymes; RNA polymerase; reverse transcriptase; RNase H; nickase; thermophilic DNA polymerase; ATP; rNTPs; and dNTPs.
  • the oligonucleotide of the kit comprises a RNA polymerase promoter sequence, such as a T7 RNA polymerase promoter sequence, for example.
  • the one or more endonucleases may be methylation-specific, methylation-sensitive, or may be a homing endonuclease.
  • methods of the invention occur in a single suitable solution, wherein the process of preparing and amplifying of a oligonucleotide-attached nucleic acid molecule occurs in the absence of exogenous manipulation.
  • the method may be further defined as occurring at one temperature, such as between about 10° C. to about 85° C. or between about 10° C. to about 85° C.
  • the method is further defined as occurring at least two different temperatures, such as wherein at least one of the temperatures is from about 10° C. to about 100° C.
  • the oligonucleotide-attached nucleic acid molecule is immobilized to a solid support, such as non-covalently or covalently.
  • Some methods of the invention further comprise the step of digesting the DNA molecule with an endonuclease to generate DNA fragments, wherein the oligonucleotide becomes attached to one strand of the DNA fragment, wherein strand displacement polymerization of the oligonucleotide-ligated DNA fragment and its arrest at a base or sequence in the loop or in a region of the stem adjacent to the loop generates a 5′ overhang, and wherein the single stranded 5′ overhang hybridizes to a complementary oligonucleotide covalently immobilized to a solid support.
  • Additional embodiments of the invention include a library of DNA molecules prepared by the methods of the invention.
  • a method of preparing a DNA molecule comprising: providing an oligonucleotide; and mixing the oligonucleotide with a double stranded DNA molecule, such that upon attachment of the oligonucleotide to the double stranded DNA molecule, the oligonucleotide attached to the DNA molecule is capable of demonstrating a function that it was incapable of before the attachment to the double stranded DNA molecule, thereby producing an oligonucleotide-attached DNA molecule suitable for modification.
  • the method occurs in a single suitable solution, wherein the process occurs in the absence of exogenous manipulation.
  • Exemplary modifications include site-specific nicking, site-specific double-strand cleavage, transcription, recombination, amplification, polymerization, nick translation, strand displacement, immobilization or a combination thereof.
  • composition comprising a stem-loop oligonucleotide, said oligonucleotide comprising an inverted repeat, a loop and at least one thermo-sensitive site or site capable of becoming a thermo-sensitive site, wherein the oligonucleotide is capable of producing a suitable primer upon exposure to heat.
  • the composition further comprises a repair enzyme, such as one capable of converting damaged bases into an abasic site.
  • DNA repair enzymes include a DNA glycosylase, such as dU-glycosylase, for example.
  • the thermo-sensitive site is an abasic site, such as an apyrimidine site or an apurine site, for example.
  • the site capable of becoming a thermo-sensitive site is further defined as a base that can be enzymatically converted to a thermo-sensitive site.
  • the base that can be enzymatically converted to a thermo-sensitive site may be deoxy-uridine and the enzyme may be dU-glycosylase (which is also referred to as Uracyl-DNA Glycosylase or UDG).
  • the thermo-sensitive site is introduced into the oligonucleotide during synthesis, such as chemical synthesis.
  • the composition may be capable of comprising a breakage of a strand of the oligonucleotide at one or more deoxy-uridine bases upon exposure to heat.
  • the thermosensitive site or site capable of becoming a thermo-sensitive site may be located in the stem, in the loop, or both.
  • the oligonucleotide may be blunt ended or have a 5′ overhang.
  • a method of producing a primer comprising providing a composition of the invention and subjecting the composition to heat such that the primer is produced.
  • the composition further comprises a DNA repair enzyme and the subjecting to heat is further defined as subjecting to two or more exposures of heat.
  • One exposure to heat may comprise about 37° C. and another exposure to heat may comprise about 95° C.
  • One exposure to heat may comprise about 10° C. to about 100° C. whereas another exposure to heat may comprise about 80° C. to about 100° C.
  • the method may further comprise amplification of a DNA molecule utilizing said composition.
  • FIG. 1A shows a standard multi-step DNA adaptor attachment process.
  • FIG. 1B compares preparation processes for WGA and WMA libraries from degraded serum and urine DNA described in the present invention and in previously filed patent applications (U.S. patent application Ser. No. 11/071,864, filed Mar. 3, 2005).
  • FIG. 1C is a general representation of the invention that can be described as a reduction of several important multi-step enzymatic DNA processes to a single-step multiplexed enzymatic reaction that is performed in one reaction volume (Enz-O-Mix Method).
  • FIG. 2 shows that the Enz-O-Mix approach can be viewed as a simple and cost-effective alternative to the “lab-on-a chip” microfluidic approach that is currently attempting to solve the same problem by reduction of reaction volumes and integration of multiple reactions into a small format.
  • FIG. 3 is a schematic description and composition of specific components of the Enz-O-Mix method and reagents involved in the attachment of stem-loop oligonucleotides to DNA ends.
  • Four enzymatic reactions are taking place nearly simultaneously: “polishing” of the DNA ends and the hairpin double-stranded stem-region; ligation of the stem-loop oligonucleotide 3′ end to the 5′ phosphate of the DNA, leaving a nick between the 3′ end of DNA and the 5′ end of the hairpin double-stranded stem-region; polymerase extension of the 3′ DNA end that propagates toward the end of stem-loop oligonucleotide; and by strand-displacement reaction within the oligonucleotide stem region.
  • the process results in the library of DNA fragments with inverted repeat sequences at their ends.
  • FIG. 4 shows three original secondary structures of the stem-loop oligonucleotide with the 3′ or 5′ protruding, or blunt end, and its final (blunt end) structure within the Enz-O-Mix.
  • FIGS. 5A-5B are schematic descriptions of the amplification of a library of DNA fragments with inverted repeat sequences at their ends by RNA transcription.
  • Promoter sequence can be added to a DNA end either as a part of the oligonucleotide stem-region (A), or as a part of the oligonucleotide loop region (B).
  • the products of the amplification are RNA molecules in this embodiment.
  • FIG. 6A illustrates the components and enzymatic reactions involved in the one-step DNA amplification by transcription using Enz-O-Mix reagent (Enz-O-Mix 5 in FIG. 19B , for example).
  • the process linearly amplifies DNA and produces single stranded RNA molecules.
  • FIG. 6B illustrates additional components and enzymatic reactions involved in the one-step DNA amplification by transcription accompanied by the synthesis of complementary cDNA strand.
  • the transcription (replication) block (see Sections E-H and FIGS. 8-10 ) is introduced into the stem-loop oligonucleotide upstream of the T7 promoter region to prevent formation of an inverted repeat at the 3′ end of RNA molecules and thus increase the efficiency of the oligo T7 priming (the transcription block is shown as a black square).
  • the process can linearly amplify DNA and produce double stranded DNA/RNA hybrids.
  • FIG. 7 is an illustration of the inhibitory effect on PCR of inverted repeats attached to both ends of DNA fragments. Heating and replication generates DNA molecules refractory to melting, priming, and PCR amplification either using the universal primer A or any internal site-specific primer pair.
  • FIG. 8 is a schematic description of the one-step Enz-O-Mix attachment process for a stem-loop oligonucleotide with non-replicable linker.
  • the following enzymatic reactions are taking place nearly simultaneously: “polishing” of the DNA ends and the stem-loop oligonucleotide double-stranded stem-region; ligation of the oligonucleotide 3′ end to the 5′ phosphate of the DNA, leaving a nick between the 3′ end of DNA and the 5′ end of the hairpin double-stranded stem-region; polymerase extension of the 3′ DNA end that propagates toward the end of oligonucleotide and stops at the replication block (non-replicable linker) within the loop or outside the loop but no more than about six bases away from the loop.
  • the process results in the library of DNA fragments with universal sequence A at the ends and an inverted repeat attached only to the 5′ end of DNA.
  • FIG. 9 is an illustration of the absence of an inhibitory effect on PCR of inverted repeats attached to only 5′ ends of DNA fragments. Heating and replication generates DNA molecules with the universal sequence A and no inverted repeats at the ends (shown by dash lines) that can be successfully amplified by PCR.
  • FIG. 10A shows the structure of a stem-loop oligonucleotide with non-replicable linker introduced chemically during oligonucleotide synthesis and detailed events occurring at a DNA end during the multi-enzyme attachment process. The process occurs as described in FIG. 8 .
  • FIG. 10B shows the structure of a stem-loop oligonucleotide with non-replicable linker introduced enzymatically during the attachment reaction and detailed events occurring at a DNA end during the multi-enzyme attachment process.
  • dU-glycosylase generates abasic sites within the loop and upper strand of the stem region of the stem-loop oligonucleotide.
  • the abasic sites within a loop generate a non-replicable region, while the sites in a stem destabilize the duplex and facilitate strand displacement reaction.
  • the process results in a library of DNA fragments with universal sequence at the ends and an inverted repeat attached only to the 5′ end of DNA. Heating at 95° C. during PCR generates breaks at abasic sites and completely eliminates the 5′ portion of a stem-loop oligonucleotide.
  • FIG. 11A shows a standard adaptor formed by two different oligonucleotides, wherein one of them has a 5′ phosphate group, and possible products formed when such adaptor is used in the multi-enzyme one-step ligation process.
  • FIG. 11B shows a standard adaptor formed by two different oligonucleotides without phosphate group and two products formed when such an adaptor is used in the multi-enzyme one-step ligation process. Only 50% of formed molecules are desirable products with correct orientation of the adaptor, whereas the other 50% of molecules have inverse adaptor orientation.
  • FIG. 11C shows a standard adaptor formed by two different oligonucleotides without a phosphate group, a protective group at the 3′ end of one oligonucleotide, and products formed when such an adaptor is used in the multi-enzyme one-step ligation process.
  • FIG. 11B shows a standard adaptor formed by two different oligonucleotides without a phosphate group, a protective group at the 3′ end of one oligonucleotide, and products formed when such an adaptor is used in the multi-enzyme one-step ligation process.
  • FIG. 11B shows a standard adaptor formed by two different oligonucleotides without a phosphate group, a protective group at the 3′ end of one oligonucleotide, and products formed when such an adaptor is used in the multi-enzyme one-step ligation process.
  • FIG. 11B shows a standard adaptor formed by two different oligonucleotides without
  • FIG. 12 is a schematic description of the one-step Enz-O-Mix attachment process for a stem-loop oligonucleotide with an enzymatically cleavable site generated during the multi-enzyme reaction.
  • the endonuclease recognizes and cuts the oligonucleotide specific oligo-sequence R when it adopts a double-stranded conformation as a result of the attachment process.
  • the reaction results in a library of DNA fragments with universal sequence A at the ends and no inverted repeat attached to the ends of DNA fragments.
  • FIG. 13A shows the stem-loop oligonucleotide with the recognition sequence for the restriction endonuclease Eco NI located at the loop region.
  • the enzyme can not cut the CCTNNNNNAGG (SEQ ID NO: 20) region within the stem-loop oligonucleotide (not a recognizable structure) but it can cut it efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation.
  • FIG. 13B shows the stem-loop oligonucleotide with the recognition sequence for the restriction endonuclease PacI located within the loop region.
  • the enzyme can not cut the single stranded TTAATTAA region within the stem-loop oligonucleotide, but it cuts it efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-strand) Watson-Crick conformation.
  • FIG. 13C shows the stem-loop oligonucleotide with the recognition sequence for the exemplary homing endonuclease I-Ceu I located within the loop region.
  • the enzyme can not cut the 26-base single-stranded region within the hairpin loop, but it cuts efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation.
  • FIG. 14 is a schematic description of the one-step Enz-O-Mix attachment process for a stem-loop oligonucleotide with a very short stem.
  • the process results in the library of DNA fragments with universal sequence A at the ends and very short inverted repeat attached to the ends of DNA fragments. Amplification by PCR is possible, because the melting temperature for terminal hairpins is low enough to prevent folding, self-priming and formation of long hairpin molecules, as shown on FIG. 7 .
  • FIG. 15 illustrates the components and enzymatic reactions involved in exemplary one-step or two-step (after library synthesis) DNA amplification by strand displacement DNA synthesis using Enz-O-Mix reagents (Enz-O-Mix 3 and Enz-O-Mix 6 in FIGS. 19A and 19B , for example).
  • the amplification is initiated and further maintained by the generation of a nick within the attached oligonucleotide sequence.
  • the process linearly amplifies DNA and produces double stranded DNA molecules.
  • FIG. 16A shows the stem-loop oligonucleotide with the recognition sequence for the nicking endonuclease N.Bbv CIA located at the loop region.
  • the enzyme can not cut the single stranded GCTGAGG region within the stem-loop oligonucleotide (not a recognizable structure) but it can nick it efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation.
  • FIG. 16B shows a stem-loop oligonucleotide with the recognition sequence for the nicking endonuclease N.Bbv CIA located at the end of a stem region.
  • the enzyme can not nick efficiently the GCTGAGG region within the stem-loop oligonucleotide (it is too close to the end) but it can nick it efficiently when the oligonucleotide is attached to a DNA end; the second site generated by attachment is not a good substrate for nicking (it is too close to the end).
  • FIG. 16C shows two exemplary multifunctional stem-loop oligonucleotides with several regulatory elements within a single (1) or multiple (2) loop regions: T7 promoter sequence (that includes all regions necessary for transcription), recognition sequence N for a nicking endonuclease, recognition sequence for a restriction endonuclease, and a replication/transcription block region (a chemical modification or a string of 2-4 dU bases).
  • a multifunctional stem loop oligonucleotide can support different types of DNA amplification, including PCR, isothermal amplification by transcription, isothermal amplification by strand displacement synthesis, or even a combination thereof and it can also facilitate other modifications, including DNA immobilization, DNA recombination, DNA cloning, and a combination thereof, for example.
  • FIG. 17 shows generalization of the Enz-O-Mix method and demonstrates specific but exemplary applications.
  • FIG. 18 shows composition of five exemplary different Stem-Loop Oligo Attachment Master Mixes of the invention that are used for the one-step nucleic acid library synthesis.
  • FIG. 19A schematically shows compositions of several Enz-O-Mix reagents, specifically, Enz-O-Mix 1, designed to convert fragmented DNA into a Whole Genome Library that can be amplified by PCR in an open, or close-tube format.
  • Enz-O-Mix 2 and Enz-O-Mix 3 are designed to convert fragmented DNA into a Whole Genome Library that can be amplified after or during the Whole Genome Library synthesis by transcription and strand displacement, respectively.
  • FIG. 19B shows schematically compositions of several Enz-O-Mix reagents, specifically, Enz-O-Mix 4, designed to convert HMW DNA into a Whole Genome Library that can be amplified by PCR in an open, or close-tube format.
  • Enz-O-Mix 5 and Enz-O-Mix 6 are designed to convert fragmented DNA into a Whole Genome Library that can be amplified after or during the Whole Genome Library synthesis by transcription and strand displacement, respectively.
  • FIG. 19C shows schematically compositions of several Enz-O-Mix reagents, specifically, Enz-O-Mix 7, designed to convert fragmented DNA into a Whole Methylome Library that can be amplified by PCR.
  • Enz-O-Mix 8 and Enz-O-Mix 9 are designed to convert fragmented DNA into a Whole Methylome Library that can be amplified after or during the Whole Methylome Library synthesis by transcription and strand displacement, respectively.
  • FIG. 19D shows schematically compositions of several Enz-O-Mix reagents, specifically, Enz-O-Mix 10, designed to convert HMW DNA into a Whole Methylome Library that can be amplified by PCR.
  • Enz-O-Mix 11 and Enz-O-Mix 12 are designed to convert fragmented DNA into a Whole Methylome Library that can be amplified after or during the Whole Methylome Library synthesis by transcription and strand displacement, respectively.
  • FIG. 19E shows schematically compositions of Enz-O-Mix reagents 13 and 14 designed to convert fragmented and HMW DNA, respectively, into a Whole Genome Library that can be directly cloned into an appropriate vector.
  • FIG. 20 illustrates assembly, storage and use of Enz-O-Mix reagent(s) as a kit in high throughput applications and clinical diagnostics, for example.
  • FIG. 21A demonstrates the optimization process for Enz-O-Mix Universal Buffer using real-time PCR to monitor amplification of the generated library.
  • FIG. 21B demonstrates the optimization process for Enz-O-Mix incubation temperature using real-time PCR to monitor amplification of the generated library.
  • FIG. 21C demonstrates the optimization process for Enz-O-Mix reagent (N) concentration using real-time PCR to monitor amplification of the generated library.
  • FIG. 22 shows real-time amplification curves of whole genome libraries prepared in a single step by ligation of a stem-loop oligonucleotide with EcoNI restriction site generated after ligation and strand-displacement extension of blunt-end AluI restriction fragments in the presence or in the absence of EcoNI. Excision of the terminal inverted repeat by EcoNI results in high amplification efficiency that exceeds amplification efficiency of the library with inverted repeats (in the absence of the Eco NI cleavage) by two orders of magnitude.
  • FIG. 23 shows real-time amplification curves of libraries prepared in a single step by ligation of blunt-end AluI restriction fragments to the stem-loop oligonucleotide comprising hexa-ethylene glycol replication stop (HEG Stem-Loop Oligo), a stretch of 5 ribonucleosides (Ribo Stem-Loop Oligo), or just deoxyribonucleosides (Stem-Loop Oligo) in their loop regions.
  • HEG Stem-Loop Oligo hexa-ethylene glycol replication stop
  • Ribo Stem-Loop Oligo a stretch of 5 ribonucleosides
  • Stem-Loop Oligo just deoxyribonucleosides
  • the libraries with ribonucleosides in the loop region are not amplified efficiently, suggesting that ribonucleosides in the template strand do not arrest DNA replication carried by the Klenow fragment of DNA polymerase I.
  • FIGS. 24A, 24B , and 24 C show the real-time PCR amplification curves of 3 exemplary human STS markers used for evaluation of genomic sequence representation in WGA libraries prepared in a single step by ligation of blunt-end AluI restriction fragments to a stem-loop oligonucleotide containing within a loop either the hexa-ethylene glycol linker (HEG) as a replication stop, or the EcoNI recognition sequence that becomes functional (cleavable) after ligation and strand-displacement extension. Twenty nanograms of purified material of each library is compared to 1 ng of human genomic DNA randomly fragmented to an average size of 1.5 Kb using Hydro Shear device (gDNA).
  • HOG hexa-ethylene glycol linker
  • gDNA Hydro Shear device
  • FIG. 25 shows the real-time amplification curves of libraries prepared in a single step by ligation of blunt-end AluI restriction fragments to the stem-loop oligonucleotide containing deoxy-uridine in the 5′ stem region and in the loop with T4 DNA ligase and Klenow fragment of DNA polymerase I, in the presence or in the absence Uracil-DNA glycosylase (which is also referred to as UDG or dU glycosylase).
  • Amplification is conducted by either adding universal primer M U or using the primer released as a result of the UDG activity, followed by heat-induced degradation of the stem-loop oligonucleotide.
  • FIG. 26 illustrates a one-step genomic DNA restriction digestion and whole genome amplification using degradable stem-loop oligonucleotide containing deoxy-uridine in the 5′ stem region and in the loop.
  • Human genomic DNA in amounts ranging from 20 ng to 10 pg or a blank sample (no DNA control) are incubated with the stem-loop oligonucleotide in the presence of 4 exemplary enzymatic activities: AluI restriction endonuclease, T4 DNA ligase, Klenow fragment of DNA polymerase I, and Uracil-DNA glycosylase (UDG) for 1 hour at 37° C. and amplified by PCR using universal primer M U .
  • FIG. 27 shows PCR amplification curves of specific promoter sites from amplified libraries prepared from non-methylated (N) and artificially methylated (M) cell-free urine DNA from a healthy donor.
  • Libraries were prepared by ligation of a degradable stem-loop oligonucleotide containing deoxy-uridine with (N+, M+) or without (N ⁇ , M ⁇ ) simultaneous cleavage with methylation-sensitive restriction enzymes.
  • Promoter sites from non-methylated cleaved DNA (N+) amplify with significant (at least 10 cycles) delay as compared to uncut DNA (N ⁇ , M ⁇ ) unlike methylated DNA which is refractory to cleavage (M+ versus M ⁇ ).
  • FIG. 28 shows the products of simultaneous whole bacteriophage DNA library synthesis and isothermal amplification by T7 polymerase transcription of lambda DNA digested with restriction endonuclease Bst EII on an agarose gel in the presence (+T4 ligase) or absence of DNA ligase ( ⁇ T4 ligase).
  • FIG. 29 shows the products of simultaneous library synthesis and isothermal amplification of cell-free urine DNA using the nicking activity of the nuclease N.BbvC IB and strand displacement DNA synthesis.
  • FIGS. 30A-30B compare two Enz-O-Mix library synthesis/PCR amplification processes (Enz-O-Mix 1 and Enz-O-Mix 4 from FIGS. 19A and 19B ).
  • FIG. 30A shows a 2-step, opened-tube protocol.
  • Enz-O-Mix library synthesis/amplification is performed in two operational steps: step 1 —a tube containing DNA is supplemented with the library (WGA or WMA) synthesis reagents and incubated at 37° C. for 1 h, and step 2 —the tube is opened, supplemented with PCR amplification buffer/reagents and subjected to temperature cycling.
  • FIG. 30B shows a 1-step, closed-tube protocol.
  • Enz-O-Mix library synthesis/amplification is performed in one operational step when a tube containing DNA is supplemented with the library synthesis/amplification (PCR) reagents and universal buffer, and subjected to programmed temperature conditions within a thermocycler.
  • PCR library synthesis/amplification
  • FIG. 31 shows an expected accumulation of DNA in a tube (a) and a typical temperature profile (b) for a one-step, closed tube Enz-O-Mix PCR-based WGA or WMA.
  • FIG. 32 illustrates heat-induced conversion of a stem-loop oligonucleotide adaptor containing dU-bases within the loop and the 5′ stem region into a functional universal PCR primer.
  • FIG. 33 shows effect of DMSO and magnesium concentration on the whole genome amplification of HMW human DNA isolated from blood using integrated one-step, closed-tube Enz-O-Mix protocol illustrated in FIGS. 30, 31 , and 32 , and real-time PCR detection.
  • FIG. 34 illustrate application of the one-step, closed tube Enz-O-Mix WGA process (DNA fragmentation, amplification, and labeling) for micro-array analysis.
  • FIGS. 35A and 35B show the one-step process for simultaneous GenomePlex or MethylPlex library synthesis and immobilization.
  • FIG. 35A there is non-covalent library immobilization by hybridization of the exposed 5′ stem region to an oligo S covalently attached to a tube/well surface.
  • FIG. 35B there is a covalent library immobilization by hybridization and ligation of the exposed 5′ stem region to an oligo S covalently attached to a tube/well surface.
  • FIG. 36 shows tubes, plates, micro-slides, and micro-beads manufactured for one-step GenomePlex or MethylPlex library synthesis and immobilization.
  • FIG. 37 shows a hypothetical fluidic device that utilizes the one-step GenomePlex or MethylPlex library synthesis and immobilization process.
  • FIG. 38 illustrates hot start locus-specific PCR amplification of DNA using degradable stem-loop primers.
  • FIG. 39 shows the specific events that lead to a conversion of the inactive stem-loop oligonucleotides into the active PCR primers.
  • FIG. 40 shows accumulation of a specific PCR product (A) and a typical temperature profile (B) for a hot start PCR using degradable stem-loop primers
  • R refers to A or G
  • Y refers to C or T
  • M refers to A or C
  • K refers to G or T
  • S refers to C or G
  • W refers to A or T
  • H refers to A or C or T
  • B refers to C or G or T
  • V refers to A or C or G
  • D refers to A or G or T
  • N refers to A or C or G or T.
  • blunt end refers to the end of a dsDNA molecule having 5′ and 3′ ends, wherein the 5′ and 3′ ends terminate at the same nucleotide position. Thus, the blunt end comprises no 5′ or 3′ overhang.
  • double stranded molecule refers to a molecule that is double stranded at least in part.
  • homose refers to proteins that are encoded by polynucleotides having mobile, self-splicing introns. Homing endonucleases promote the movement of at least part of the DNA sequences that encode them from one polynucleotide location to another by generating a site-specific double-stranded break at a target site in an allele that lacks the corresponding mobile intron. Examples include but are not limited to at least the following: I-Ceu I, I-Sce I, Pl-Psp I, Pl-Sce I, or a mixture thereof.
  • hairpin and “stem-loop oligonucleotide” as used herein refer to a structure formed by an oligonucleotide comprised of 5′ and 3′ terminal regions that are inverted repeats and a non-self-complementary central region, wherein the self-complementary inverted repeats form a double-stranded stem and the non-self-complementary central region forms a single-stranded loop.
  • the term “in the absence of exogenous manipulation” as used herein refers to there being modification of a DNA molecule without changing the solution in which the DNA molecule is being modified. In specific embodiments, it occurs in the absence of the hand of man or in the absence of a machine that changes solution conditions, which may also be referred to as buffer conditions. In further specific embodiments, changes in temperature occur during the modification.
  • nonidentical function refers to two or more enzymes that do not comprise the same activity.
  • two restriction endonucleases would be considered to have identical function, although a restriction endonuclease and a ligase would be considered to have nonidentical function.
  • endonucleases are defined as enzymes that cut double stranded DNA and therefore that have identical function, although this may be performed in a variety of ways.
  • restriction endonucleases cut frequently enough that they may be considered to have a DNA fragmentation function (such as to reduce an average DNA size to the size appropriate for efficient WGA, for example), and other restriction endonucleases have a function of cleaving unmethylated restriction sites, for example to generate a Methylome library (such as cleavage that would not reduce an average DNA size), for example.
  • the term “polished” as used herein refers to the repair of dsDNA fragment termini that may be enzymatically repaired, wherein the repair constitutes the fill in of recessed 3′ ends or the exonuclease activity trimming back of 5′ ends to form a “blunt end” compatible with adaptor ligation.
  • the present invention may employ particular compositions and methods as described in the following exemplary embodiments.
  • DNA is incubated with an exemplary mixture comprising a stem-loop oligonucleotide with 3′ recessed, 3′ protruding, or blunt end ( FIG. 4 ); a 3′ proofreading DNA polymerase (Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.); T4 DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs.
  • a stem-loop oligonucleotide with 3′ recessed, 3′ protruding, or blunt end FIG. 4
  • a 3′ proofreading DNA polymerase Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.
  • T4 DNA ligase Enz-O-Mix Universal Buffer
  • ATP ATP
  • dNTPs dNTPs
  • exemplary enzymatic reactions are taking place simultaneously: “polishing” of the DNA ends and the oligonucleotide double-stranded stem-region; ligation of the oligonucleotide 3′ end to the 5′ phosphate of the DNA leaving a nick between the 3′ end of DNA and the 5′ end of the oligonucleotide double-stranded stem-region; polymerase extension of the 3′ DNA end that propagates toward the end of the stem-loop oligonucleotide; and a strand-displacement reaction within the oligonucleotide stem region.
  • the process results in a library of DNA fragments with inverted repeat adaptors at their ends.
  • a DNA library produced by incubation with an exemplary mixture comprising a stem-loop oligonucleotide with 3′ recessed, 3′ protruding, or blunt end ( FIG. 4 ) and T7 promoter sequence within the stem or loop region; a 3′ proofreading DNA polymerase (Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.); T4 DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs (as shown in FIG. 3 ), is used as a template for the transcription-mediated amplification.
  • a stem-loop oligonucleotide with 3′ recessed, 3′ protruding, or blunt end FIG. 4
  • T7 promoter sequence within the stem or loop region a 3′ proofreading DNA polymerase (Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.)
  • T4 DNA ligase Enz-O-Mix Universal Buffer
  • promoter sequence resides within the stem region of a stem-loop oligonucleotide, and there are two inversely oriented promoters at the ends of all DNA fragments: internally located promoter that initiates synthesis of long RNA molecules, and terminal promoter that initiates synthesis of very short ( ⁇ 10 bases) RNA initiation products (not shown in FIG. 5A ) (similar products will be produced from the non-attached stem-loop oligonucleotides present in the mixture).
  • FIG. 5B the promoter sequence resides within the loop region of a stem-loop oligonucleotide, and there is only one active promoter element that supports synthesis of long RNA products.
  • the transcription-mediated amplification is achieved by incubation of the synthesized DNA library (see above) with T7 RNA polymerase in the presence of ribonucleotides (rNTPs). The products of this reaction are RNA molecules.
  • Supplementation of a transcription-mediated amplification reaction with additional ingredients such as a reverse transcriptase polymerase (M-MuLV reverse transcriptase, AMV reverse transcriptase, etc.) and a primer complementary to the T7 promoter or the internal stem region at the 3′ end of the RNA molecule (see FIG. 6B ), would allow the synthesis of a complementary cDNA.
  • Efficient priming at the 3′ ends of RNA is achieved by blocking the transcription-mediated RNA synthesis within the adaptor region to prevent formation of a folded structure at the 3′ ends of RNA.
  • Transcriptional arrest can be achieved by using the same chemical or enzymatic modifications of a stem-loop oligonucleotide as described herein in Sections E, F, G, and H and shown in FIGS. 8, 10 , and 16 C.
  • the products of such a reaction are double stranded DNA/RNA hybrid molecules.
  • FIG. 6A illustrates exemplary components and enzymatic reactions involved in the process catalyzed by Enz-O-Mix reagent (Enz-O-Mix 5, FIG. 19B ).
  • This reagent simultaneously synthesizes a DNA library with T7 promoter at the ends and amplifies it linearly by transcription.
  • the Enz-O-Mix reagent 5 comprises a stem-loop oligonucleotide with T7 promoter sequence in the loop region; a DNA fragmentation endonuclease (a restriction enzyme, DNase I, methylation-specific nuclease McrBC, benzonase, apoptotic endonuclease, etc.); a 3′ proofreading DNA polymerase; T4 DNA ligase; T7 RNA polymerase; Enz-O-Mix Universal Buffer; rNTP; and dNTPs.
  • a DNA fragmentation endonuclease a restriction enzyme, DNase I, methylation-specific nuclease McrBC, benzonase, apoptotic endonuclease, etc.
  • a 3′ proofreading DNA polymerase T4 DNA ligase
  • T7 RNA polymerase Enz-O-Mix Universal Buffer
  • rNTP Enz-O-
  • the T4 DNA polymerase “polishes” the DNA ends and the stem-loop oligonucleotide double-stranded stem-region, and T4 ligase ligates the 3′ end of the oligonucleotide to the 5′ phosphate of the DNA leaving a nick between the 3′ end of DNA and the 5′ end of the oligonucleotide double-stranded stem-region.
  • DNA polymerase extends the available 3′ DNA end toward the end of a stem-loop oligonucleotide and generates a library of DNA fragments with active conformation of T7 promoter at their ends.
  • RNA polymerase transcribes the library, linearly amplifying DNA and producing single stranded RNA molecules.
  • fragmented DNA for example, cell-free DNA from blood and/or urine
  • the reaction does not require a fragmentation endonuclease (Enz-O-Mix 2, FIG. 19A ); all other components may be the same as described above.
  • supplementation of a transcription-mediated amplification reaction with the additional ingredients allows the synthesis of a complementary cDNA.
  • Efficient priming at the 3′ ends of RNA is achieved by blocking the transcription-mediated RNA synthesis within the adaptor region to prevent formation of a folded structure at the 3′ ends of RNA.
  • Transcriptional arrest can be achieved by using the same chemical or enzymatic modifications of a stem-loop oligonucleotide as described herein in Sections E, F, G, and H and shown in FIGS. 8, 10 , and 16 C.
  • the products of such a reaction are double stranded DNA/RNA hybrid molecules.
  • inverted repeats attached to both ends of DNA fragments have an inhibitory effect on PCR process.
  • Heating to 95° C. during a first PCR cycle denatures DNA strands and generates hairpin-like structures at both 3′ and 5′ ends of DNA fragments due to the folding of terminal inverted repeat sequences (the melting temperature for these structures is usually more than 100° C.).
  • Subsequent cooling activates a thermostable DNA polymerase and results in extension of the self-primed 3′ ends and creation of long hairpin DNA molecules refractory to melting, priming, and PCR amplification.
  • the universal primer A nor any internal, site-specific primer pair would produce any detectable PCR product.
  • FIG. 8 This embodiment is illustrated in FIG. 8 and describes the one-step Enz-O-Mix attachment process for a stem-loop oligonucleotide with a non-replicable linker.
  • the exemplary reaction mix comprises fragmented DNA; a stem-loop oligonucleotide with 3′ recessed, 3′ protruding or blunt end ( FIG. 4 ), and a non-replicable linker (such as about in the central part of the oligonucleotide); a 3′ proofreading DNA polymerase (Klenow fragment of the DNA polymerase 1, T4 DNA polymerase, etc.); T4 DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs.
  • At least the following enzymatic reactions are taking place: “polishing” of the DNA ends and the stem-loop oligonucleotide double-stranded stem-region; ligation of the oligonucleotide 3′ end to the 5′ phosphate of the DNA, leaving a nick between the 3′ end of DNA and the 5′ end of the oligonucleotide double-stranded stem-region; polymerase extension of the 3′ DNA end that propagates toward the end of stem-loop oligonucleotide and stops somewhere within the loop or close to the loop region at the replication block, for example.
  • the process results in the library of DNA fragments with universal sequence A at the ends and an inverted repeat attached only to the 5′ end of DNA.
  • a DNA library produced by the Enz-O-Mix (Enz-O-Mix 1 in the case of fragmented DNA, FIG. 19A , or Enz-O-Mix 4 in the case of HMW DNA, FIG. 19B ) attachment process with a stem-loop oligonucleotide with a non-replicable linker has no inhibitory effect on WGA and PCR. Heating to 95° C. during first PCR cycle denatures DNA strands and generates hairpin-like structures only at the 5′ ends of DNA fragments.
  • the universal primer A anneals to the A′ region at the 3′ ends of DNA fragments, and a thermostable DNA polymerase replicates DNA until it reaches a non-replicable linker in the loop or in the region adjacent to the loop stem region of the stem-loop oligonucleotide attached to the 5′ DNA end. Replication of the hairpin region is accompanied by a strand-displacement reaction within the oligonucleotide stem region. Synthesized DNA molecules with the universal sequence A and no inverted repeats at the ends (shown by dashed lines) can then successfully be amplified by PCR.
  • FIG. 10A shows the structure of a stem-loop oligonucleotide with a non-replicable linker introduced chemically during oligonucleotide synthesis and shows detailed events occurring at DNA end during the exemplary multi-enzyme attachment process.
  • Many structural modifications within the oligonucleotide such as the exemplary hexaethelene glycol linker, the abasic site, or a cluster of abasic sites (a gap), a bulky group within the base or backbone, etc. can block propagation of the DNA replication.
  • the exemplary process occurs as described in FIG. 8 .
  • FIG. 10B shows the structure of a stem-loop oligonucleotide with non-replicable linker introduced enzymatically during the attachment reaction and shows detailed events occurring at a DNA end during the exemplary multi-enzyme attachment process.
  • the exemplary reaction mix comprises fragmented DNA; a stem-loop oligonucleotide with 3′ recessed, 3′ protruding or blunt end ( FIG. 4 ), and dU bases within the loop and stem regions (optional); a dU-glycosylase; a 3′ proofreading DNA polymerase; T4 DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs.
  • dU-glycosylase creates abasic sites within the loop and upper strand of the stem region of the oligonucleotide; DNA polymerase “polishes” the ends of DNA and the stem-loop oligonucleotide and generates blunt ends; T4 DNA ligase attaches the 3′ end of the oligonucleotide and the 5′ end of DNA fragment, leaving a nick between the 3′ end of DNA and the 5′ end of the hairpin double-stranded stem-region; a DNA polymerase extends the 3′ end of DNA toward the end of the stem-loop oligonucleotide and stops somewhere within the loop or close to the loop region of the oligonucleotide, such as at the replication block generated by a contiguous abasic site region.
  • abasic sites in the about central stem region is to destabilize base pairing and facilitate the strand displacement reaction.
  • the process results in a library of DNA fragments with universal sequence at both ends and an inverted repeat attached only to the 5′ end of DNA, thereby suitable for PCR amplification. Heating at 95° C. during PCR generates breaks at abasic sites and completely eliminates the 5′ portion of a stem-loop oligonucleotide.
  • This embodiment illustrates the low efficiency and problems associated with use of standard adaptors in the Enz-O-Mix attachment process, although in alternative embodiments standard adaptors may be employed.
  • FIG. 11A shows a standard adaptor formed by two different oligonucleotides, wherein one of them has the 5′ phosphate group, and possible products formed when such an adaptor is used in the multi-enzyme one-step ligation process.
  • the adaptor should be present at high concentration to provide efficient ligation to DNA ends. Because both ends of a standard adaptor can be ligated to DNA and form adaptor-adaptor conjugates (a dominating product of the reaction), a number of undesirable products may be high, and the yield of desirable molecules may be low, in certain aspects.
  • FIG. 11B shows a standard adaptor formed by two different oligonucleotides without phosphate group and two products formed when such an adaptor is used in the multi-enzyme one-step ligation process. Only 50% of formed molecules are desirable products with correct orientation of the adaptor, while the other 50% of molecules have inversed adaptor orientation.
  • FIG. 11C shows a standard adaptor formed by two different oligonucleotides without phosphate group but with a protective group at the 3′ end of one oligonucleotide and the products formed when such adaptor is used in the multi-enzyme one-step ligation process.
  • a blocked 3′ end or recessive 3′ end or both are well-known in the art and have been used to prevent formation of products with inversed adaptor orientation during ligation reaction. Presence of a 3′ proofreading DNA polymerase in the mix will replace the terminal 3′ blocked nucleotide with normal nucleotide (a), and repair and extend the recessed, blocked 3′ end (b).
  • a normal nucleotide
  • b repair and extend the recessed, blocked 3′ end
  • FIG. 12 there is a schematic description of the one-step Enz-O-Mix attachment process for a stem-loop oligonucleotide with an enzymatically cleavable site generated during the multi-enzyme reaction.
  • the reaction mix contains fragmented DNA, a stem-loop oligonucleotide with 3′ recessed, 3′ protruding or blunt end ( FIG.
  • a specific DNA sequence R within the loop or in the loop and adjacent stem region a 3′ proofreading DNA polymerase (Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.); T4 DNA ligase; an endonuclease that recognizes and cuts the oligonucleotide specific oligo-sequence R when it adopts a double-stranded conformation; Enz-O-Mix Universal Buffer; ATP; and dNTPs.
  • FIG. 13A shows an exemplary stem-loop oligonucleotide with recognition sequence for the restriction endonuclease Eco NI located at the loop region.
  • the enzyme can not cut the CCTNNNNNAGG (SEQ ID NO: 20) region within the stem-loop oligonucleotide (an unrecognizable structure) but it will cut it efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation. Cleavage with Eco NI eliminates inverted repeats that inhibit PCR applications.
  • FIG. 13B shows an exemplary stem-loop oligonucleotide with recognition sequence for the restriction endonuclease Pac I located within the loop region.
  • the enzyme can not cut the TTAATTAA region within the stem-loop oligonucleotide, but it will cut it efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation. Cleavage eliminates inverted repeats that inhibit PCR applications.
  • Use of a rare-cutting restriction enzyme such as Pac I reduces the number of DNA fragments affected by the enzyme cleavage.
  • FIG. 13C shows the stem-loop oligonucleotide with recognition sequence for the homing endonuclease I-Ceu I located within the loop region.
  • the enzyme can not cut the 26-base single-stranded region within the loop, but it cuts efficiently when the stem-loop oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation. Cleavage eliminates inverted repeats that inhibit PCR applications. Use of a homing endonuclease dramatically reduces and practically eliminates cleavage of genomic DNA.
  • Amplifiable libraries can be synthesized in the presence of but not limited to a stem-loop oligonucleotide with a non-replicable or cleavable linker.
  • FIG. 14 shows a schematic description of an exemplary one-step Enz-O-Mix attachment process using a stem-loop oligonucleotide with a very short stem.
  • the exemplary reaction mix comprises fragmented DNA, a stem-loop oligonucleotide with 3′ recessed, 3′ protruding or blunt end ( FIG.
  • a short stem region (5-8 bases); a 3′ proofreading DNA polymerase (Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.); T4 DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs.
  • Three enzymatic reactions are taking place: “polishing” of the DNA ends and the stem-loop oligonucleotide double-stranded stem-region; ligation of the oligonucleotide 3′ end to the 5′ phosphate of the DNA, leaving a nick between the 3′ end of DNA and the 5′ end of the hairpin double-stranded stem-region; and polymerase extension of the 3′ DNA end that propagates toward the end of the stem-loop oligonucleotide and generates short inverted repeats at the ends of DNA fragments.
  • the process results in a library of DNA fragments with universal sequence A at the ends and a very short inverted repeat attached to the ends of DNA fragments ( FIG. 14 , shown in bold).
  • Primer A (representing the 3′ portion of a stem-loop oligonucleotide without the complementary 5′ region) or even the whole stem-loop oligonucleotide can be utilized as a primer for PCR amplification.
  • FIG. 15 illustrates exemplary components and enzymatic reactions involved in the process catalyzed by Enz-O-Mix reagents (Enz-O-Mix 3 and Enz-O-Mix 6, FIGS. 19A and 19B ).
  • the reagent Enz-O-Mix 3 can use fragmented (cell-free serum DNA or urine DNA, for example), while the reagent Enz-O-Mix 6 can utilize HMW DNA and synthesize a library of DNA fragments with the recognition sites for a nicking endonuclease (N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.) at their ends to allow their subsequent amplification by strand displacement DNA synthesis.
  • a nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.
  • nicking endonuclease and strand displacing polymerase allows one to simultaneously synthesize and amplify DNA library by strand displacement DNA synthesis.
  • the Enz-O-Mix reagent 3 (suitable for fragmented DNA) comprises a stem-loop oligonucleotide with a recognition sequence for a nicking nuclease; a primer P complementary at least partially to the stem region of a stem-loop oligonucleotide; a 3′ proofreading DNA polymerase; a strand displacing DNA polymerase; T4 DNA ligase; a nicking endonuclease; Enz-O-Mix Universal Buffer; and dNTPs.
  • T4 DNA polymerase “polishes” the DNA ends and the stem-loop oligonucleotide double-stranded stem-region.
  • T4 ligase ligates the 3′ end of the oligonucleotide to the 5′ phosphate of the DNA, leaving a nick between the 3′ end of DNA and the 5′ end of the oligonucleotide double-stranded stem-region.
  • DNA polymerase extends the available 3′ DNA end toward the end of a stem-loop oligonucleotide and generates a library of DNA fragments with functional recognition site for a nicking endonuclease (N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.) at their ends.
  • a nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.B
  • DNA polymerase initiates multiple rounds of strand displacement DNA synthesis at nicks generated by a nicking nuclease, followed by synthesis of a second DNA strand (primed by primer P), producing double stranded DNA molecules and linearly amplifying DNA.
  • FIG. 16A shows the stem-loop oligonucleotide with recognition sequence for the exemplary nicking endonuclease N.Bbv CIA located at the loop region.
  • the enzyme can not nick the single stranded GCTGAGG region within the stem-loop oligonucleotide (an unrecognizable structure), but it will nick it efficiently when the oligonucleotide is attached to a DNA end and adopts a canonical (double-stranded) Watson-Crick conformation.
  • FIG. 16B shows an exemplary stem-loop oligonucleotide with recognition sequence for the nicking endonuclease N.Bbv CIA located at the end of the stem region.
  • the enzyme can not nick efficiently the terminally located TTAATTAA region within the stem-loop oligonucleotide, but it will nick it efficiently when the oligonucleotide is attached to a DNA end and the site acquires an internal location.
  • a second nicking site, generated by the oligonucleotide attachment process, would have a terminal location and low nicking efficiency.
  • FIG. 16C shows an exemplary stem-loop oligonucleotides 1 and 2 that contains several functional elements within the loop region including the recognition sequence for a nicking endonuclease.
  • Multifunctional stem-loop oligonucleotide have several regulatory elements within the loop region: T7 promoter sequence (that includes all regions necessary for transcription); recognition sequence N for a nicking endonuclease (N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.); recognition sequence for a restriction endonuclease; and a replication/transcription block region (a chemical modification or a string of 2-4 dU bases).
  • the regulatory elements can reside within a single loop region (L1 in the stem-loop oligonucleotide 1), or be distributed across several loop regions (L1, L2, and L3 in the stem-loop oligonucleotide 2).
  • a multifunctional stem-loop oligonucleotide can support different types of DNA amplification, including PCR, isothermal amplification by transcription, isothermal amplification by strand displacement synthesis, or even a combination thereof and can also facilitate modification such as DNA immobilization, DNA recombination, DNA cloning, or a combination thereof.
  • Activation of the RNA transcription, DNA nicking, DNA double-stranded cleavage, and generation of the 5′ overhang functions of the stem-loop adaptor occurs only upon its enzymatic processing and attachment to DNA ends.
  • This embodiment of the present invention shows generalization of the Enz-O-Mix method and demonstrates its specific applications.
  • Enz-O-Mix reagent is combined with DNA and incubated at optimal temperature (for example, 37° C.) for a time necessary to complete the reaction (for example, 1 hour), although it can be more or less, it results in either a DNA library that can be amplified or cloned in a separate reaction, or a DNA library that is amplified isothermally during the incubation with the Enz-O-Mix reagent.
  • the exemplary products of reaction could be as follows: 1) a library of DNA fragments with universal sequence or sequences attached to the ends of DNA fragments so that it can be amplified by PCR (PCR WGA Library); 2) a library of DNA fragments with a promoter sequence attached at the ends of DNA fragments so that it can be amplified by transcription (Transcription WGA Library); 3) a Methylome Library, i.e. the library of adapted DNA fragments where all non-methylated CpG islands are eliminated (such as are described in U.S. patent application Ser. No. 11/071,864, filed Mar.
  • FIG. 18 This embodiment is shown in FIG. 18 and illustrates the components of four different Stem-Loop Oligo Attachment Master Mixes described in the invention and utilized in different Enz-O-Mix reactions involved in the DNA library synthesis.
  • the Stem-Loop Oligo Attachment Master Mix is a key component of the Enz-O-Mix reaction, and it is present in all Enz-O-Mix reagents.
  • the exemplary Stem-Loop Oligo Attachment Master Mix I comprises a stem-loop oligonucleotide; a 3′ proofreading DNA polymerase; a DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs (see also FIG. 3 and FIG. 14 ).
  • the exemplary Stem-Loop Oligo Attachment Master Mix II comprises a stem-loop oligonucleotide with a non-replicable chemically introduced linker; a 3′ proofreading DNA polymerase; a DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs (see also FIG. 10A ).
  • An exemplary Stem-Loop Oligo Attachment Master Mix III comprises a stem-loop oligonucleotide with a non-replicable enzymatically-introduced abasic linker; dU-glycosylase; a 3 proofreading DNA polymerase; a DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs (see also FIG. 10B ).
  • An exemplary Stem-Loop Oligo Attachment Master Mix IV comprises a stem-loop oligonucleotide with a cleavable site introduced by DNA replication; a site-specific endonuclease; a 3 proofreading DNA polymerase; a DNA ligase; Enz-O-Mix Universal Buffer; ATP; and dNTPs (see also FIG. 12 and FIGS. 14A, 14B , and 14 C).
  • Whole Genome Amplification is a process that is used to amplify total genomic DNA for many important research and diagnostic applications when the amount of DNA is limited. WGA is frequently preceded by a multi-step WGA library synthesis process. These embodiments describe the Enz-O-Mix reagents and procedures for the one-step Whole Genome Library synthesis and combined one-step, close-tube Whole Genome Library synthesis-amplification processes.
  • FIG. 19A shows schematically compositions of three Enz-O-Mix reagents, specifically Enz-O-Mix 1, Enz-O-Mix 2, and Enz-O-Mix 3 designed to convert fragmented DNA into a Whole Genome Library competent for amplification by PCR, transcription, or strand displacement amplification, respectively.
  • Reagent Enz-O-Mix 1 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 , and it could be also supplemented with a thermophilic DNA polymerase.
  • the library prepared by the Enz-O-Mix 1 process can be used for PCR-mediated WGA in a open-tube (two-step process) or a close-tube (one-step process) formats (as shown in FIG. 30 ).
  • Reagent Enz-O-Mix 2 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case a stem-loop oligonucleotide has the T7 promoter sequence in the loop or stem region in addition to other necessary base/backbone modifications), and it could be also supplemented with the T7 RNA polymerase and rNTPs.
  • the Enz-O-Mix 2 can be used for a two-step transcription-mediated Whole Genome Amplification (when the library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Whole Genome library synthesis and its amplification by transcription occurs simultaneously (as shown in FIG. 6 ).
  • Reagent Enz-O-Mix 3 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case, a stem-loop oligonucleotide has a recognition sequence for a nicking endonuclease in the loop or stem region in addition to other necessary base/backbone modifications).
  • nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.
  • a strand displacing DNA polymerase Klenow exo-, Phi 29, Bst 1, etc.
  • primer P FIG. 15 .
  • the Enz-O-Mix 3 can be used for a two-step strand displacement-mediated Whole Genome Amplification (when the library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Whole Genome library synthesis and its amplification by a strand displacement synthesis occurs simultaneously (as shown in FIG. 15 ).
  • FIG. 19B shows schematically compositions of three Enz-O-Mix reagents, specifically Enz-O-Mix 4, Enz-O-Mix 5, and Enz-O-Mix 6 designed to convert high molecular DNA into a Whole Genome Library competent for amplification by PCR, transcription, or strand displacement amplification, respectively.
  • Reagent Enz-O-Mix 4 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 ; it is also supplemented with a DNA fragmentation endonuclease such as restriction enzyme DNase I, Benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.; and it could be also supplemented with a thermophilic DNA polymerase.
  • the library prepared by the Enz-O-Mix 4 process can be used for PCR-mediated WGA in a open-tube (two-step process) or a close-tube (one-step process) formats (as shown in FIG. 30 ).
  • Reagent Enz-O-Mix 5 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case, a stem-loop oligonucleotide has the T7 promoter sequence in the loop or stem region in addition to other necessary base/backbone modifications), and it is also supplemented with a DNA fragmentation endonuclease such as restriction enzyme DNase 1, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.; and it could be also supplemented with RNA polymerase and rNTPs.
  • a DNA fragmentation endonuclease such as restriction enzyme DNase 1, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.
  • the Enz-O-Mix 5 can be used for a two-step transcription-mediated Whole Genome Amplification of HMW DNA (when the library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Whole Genome library synthesis and its amplification by transcription occurs simultaneously (as shown in FIG. 6 ).
  • Reagent Enz-O-Mix 6 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case, a stem-loop oligonucleotide has a recognition sequence for a nicking endonuclease in the loop or stem region in addition to other necessary base/backbone modifications), and it is supplemented with a DNA fragmentation endonuclease such as restriction enzyme, DNase 1, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease.
  • a DNA fragmentation endonuclease such as restriction enzyme, DNase 1, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease.
  • nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.
  • a strand displacing DNA polymerase Klenow exo-, Phi 29, Bst 1, etc.
  • primer P FIG. 15 .
  • the Enz-O-Mix 6 can be used for a two-step strand displacement-mediated Whole Genome Amplification of HMW DNA (when the library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Whole Genome library synthesis and its amplification by a strand displacement synthesis occurs simultaneously (as shown in FIG. 15 ).
  • WMA Whole Methylome Amplification
  • FIG. 19C shows schematically compositions of three Enz-O-Mix reagents, Enz-O-Mix 7, Enz-O-Mix 8, and Enz-O-Mix 9, designed to convert fragmented DNA into a Whole Methylome Library competent for amplification by PCR, transcription, or strand displacement, for example.
  • Reagent Enz-O-Mix 7 may comprise one of Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 , and it is also supplemented with a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I, Hpa II, Hpy 99I, Hpy CH4 IV, Hsp AI, Mvn I, and Ssi I, to produce a substantial fragmentation of all non-methylated CpG islands (see, for example, U.S.
  • several methylation-sensitive restriction enzymes such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa
  • Reagent Enz-O-Mix 7 could be also supplemented with a thermophilic DNA polymerase.
  • the Methylome library prepared by the Enz-O-Mix 7 process can be used for PCR-mediated WMA in a open-tube (two-step process) or a close-tube (one-step process) formats (as shown in FIG. 30 ).
  • Reagent Enz-O-Mix 8 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case a stem-loop oligonucleotide has the T7 promoter sequence in the loop or stem region in addition to other necessary base/backbone modifications), and it is also supplemented with a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I, Hpa II, Hpy 99I, Hpy CH4 IV, Hsp AI, Mvn I, and Ssi I, to produce a substantial fragmentation of all non-methylated CpG islands (U.S.
  • Reagent Enz-O-Mix 8 could be also supplemented with T7 RNA polymerase and rNTPs.
  • the Enz-O-Mix 8 can be used for a two-step transcription-mediated Whole Methylome Amplification (when the Whole Methylome library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Methylome library synthesis and its amplification by transcription occurs simultaneously.
  • Reagent Enz-O-Mix 9 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case, a stem-loop oligonucleotide has a recognition sequence for a nicking endonuclease in the loop or stem region in addition to other necessary base/backbone modifications), and it is also supplemented with a mixture of several (about 5-12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga 1, Hha 1, HinP1I, Hin 6I, Hpa II, Hpy 99I, Hpy CH4 IV, Hsp AI, Mvn I, and Ssi I, to produce a substantial fragmentation of all non-methylated CpG islands
  • Reagent Enz-O-Mix 9 could be also supplemented with nicking endonuclease (N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.), a strand displacing DNA polymerase (Klenow exo-, Phi 29, Bst 1, etc.), and primer P ( FIG. 15 ).
  • nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.
  • a strand displacing DNA polymerase Klenow exo-, Phi 29, Bst 1, etc.
  • primer P FIG. 15
  • the Enz-O-Mix 9 can be used for a two-step strand displacement-mediated Whole Methylome Amplification (when the library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Methylome library synthesis and its amplification by a strand displacement synthesis occurs simultaneously (as shown in FIG. 15 ).
  • FIG. 19D show schematically compositions of another three Enz-O-Mix reagents, Enz-O-Mix 10, Enz-O-Mix 11, and Enz-O-Mix 12, designed to convert HMW DNA into a Whole Methylome Library competent for amplification by PCR, transcription, or strand displacement, for example.
  • Reagent Enz-O-Mix 10 may comprise one of Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 , and it is also supplemented with a DNA fragmentation endonuclease such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, and a mixture of several (about 5-12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I, Hpa II, Hpy 99I, Hpy CH4 IV, Hsp AI, Mvn I, and Ssi I, to produce a substantial fragmentation of all
  • the Methylome library prepared by the Enz-O-Mix 10 process can be used for PCR-mediated WMA in a open-tube (two-step process) or a close-tube (one-step process) formats (as shown in FIG. 30 ).
  • Reagent Enz-O-Mix 11 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case a stem-loop oligonucleotide has the T7 promoter sequence in the loop or stem region in addition to other necessary base/backbone modifications), and it is also supplemented with a DNA fragmentation endonuclease, such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.; and a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I,
  • Reagent Enz-O-Mix 11 could be also supplemented with T7 RNA polymerase and rNTPs.
  • the Enz-O-Mix 11 can be used for a two-step transcription-mediated Whole Methylome Amplification (when the Whole Methylome library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Methylome library synthesis and its amplification by transcription occurs simultaneously.
  • Reagent Enz-O-Mix 12 may comprise Stem-Loop Oligo Attachment Master Mixes shown in FIG. 18 (in this case, a stem-loop oligonucleotide has a recognition sequence for a nicking endonuclease in the loop or stem region in addition to other necessary base/backbone modifications), and it is also supplemented with a DNA fragmentation endonuclease, such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease; and a mixture of several (about 5-12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, Hin
  • Reagent Enz-O-Mix 12 could be also supplemented with nicking endonuclease (N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.), a strand displacing DNA polymerase (Klenow exo-, Phi 29, Bst 1, etc.), and primer P ( FIG. 15 ).
  • nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.
  • a strand displacing DNA polymerase Klenow exo-, Phi 29, Bst 1, etc.
  • primer P FIG. 15
  • the Enz-O-Mix 12 can be used for a two-step strand displacement-mediated whole Methylome Amplification (when the library is prepared first, and then amplified) or for a one-step ithothermal amplification process when the Methylome library synthesis and its amplification by a strand displacement synthesis occurs simultaneously (as shown in FIG. 15 ).
  • DNA cloning is a powerful tool for whole genome DNA sequencing and analysis of cDNA libraries, for example.
  • DNA is randomly fragmented, repaired, attached to linkers, and then integrated into a vector.
  • This embodiment describes the Enz-O-Mix reagents for the one-step preparation of DNA fragments with sticky ends that is easy to clone.
  • FIG. 19E shows schematically exemplary compositions of two Enz-O-Mix reagents designed to convert fragmented (Enz-O-Mix 13) or HMW DNA (Enz-O-Mix 14) into a Whole Genome Library for cloning.
  • Reagent Enz-O-Mix 13 may comprise a Stem-Loop Oligo Attachment Master Mix IV shown in FIG. 18 , and it is the only component of the Enz-O-Mix 13 reagent.
  • the library generated by the Enz-O-Mix 13 process can only utilize a fragmented DNA (for example, cell-free DNA from blood and/or urine, or DNA fragmented enzymatically or mechanically, for example) and be used for cloning.
  • Reagent Enz-O-Mix 14 may comprise a Stem-Loop Oligo Attachment Master Mix IV shown in FIG. 18 that is supplemented with a DNA fragmentation endonuclease, such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.
  • the library generated by the Enz-O-Mix 14 process can utilize HMW DNA from any type of cells and tissues and be used for cloning.
  • pre-assembled Enz-O-Mix reagents can be stored at ⁇ 20° C. and used as ready-to-use kits.
  • Exemplary pre-assembled Enz-O-Mix 1 comprises all major components of the reaction, such as a stem-loop oligonucleotide; DNA polymerase; a DNA ligase; dU-glycosylase (when the hairpin non-replicable region is generated by abasic sites); a hairpin-specific endonuclease (when the hairpin has a cleavable site generated during oligonucleotide attachment process); thermophilic DNA polymerase (close-tube WGA library synthesis/PCR-mediated amplification reaction); ATP; and dNTPs.
  • a stem-loop oligonucleotide DNA polymerase
  • DNA ligase DNA ligase
  • dU-glycosylase when the hairpin non-replicable region is generated by abasic sites
  • a hairpin-specific endonuclease when the hairpin has a cleavable site generated during oligonucleotide attachment
  • Exemplary pre-assembled Enz-O-Mix 2 comprises a stem-loop oligonucleotide with a promoter sequence in a stem or loop region; DNA polymerase; a DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during oligonucleotide attachment process); ATP; and dNTPs; In the case of close-tube, isothermal library synthesis/transcription-mediated amplification reaction it also comprises RNA polymerase and rNTPs.
  • Exemplary pre-assembled Enz-O-Mix 3 may comprise a stem-loop oligonucleotide with a nicking endonuclease sequence in a stem or a loop region; DNA polymerase; a DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site generated during oligonucleotide attachment process); a DNA fragmentation endonuclease, such as restriction enzyme(s), DNase I, Benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease etc.; ATP; and dNTP,
  • a nicking endonuclease N.Alw
  • Exemplary pre-assembled Enz-O-Mix 4 may comprise all major components of the reaction, such as a stem-loop oligonucleotide; DNA polymerase; a DNA ligase; dU-glycosylase (when the hairpin non-replicable region is created by abasic sites); a hairpin-specific endonuclease (when the hairpin has a cleavable site created during oligonucleotide attachment process); a DNA fragmentation endonuclease such as restriction enzyme, DNase I, Benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease thermophilic DNA polymerase (close-tube WGA library synthesis/PCR-mediated amplification reaction); ATP; and dNTPs.
  • a stem-loop oligonucleotide DNA polymerase
  • DNA ligase DNA ligase
  • dU-glycosylase when the
  • Exemplary pre-assembled Enz-O-Mix 5 may comprise a stem-loop oligonucleotide with a promoter sequence in a stem or loop region; DNA polymerase; DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during the oligonucleotide attachment process); a DNA fragmentation endonuclease, such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.; ATP; and dNTPs.
  • RNA polymerase DNA ligase
  • dU-glycosylase when the non-replicable region is formed by abasic sites
  • a site-specific endonuclease when the
  • Exemplary pre-assembled Enz-O-Mix 6 comprises a stem-loop oligonucleotide with a nicking endonuclease sequence in a stem or a loop region, DNA polymerase, a DNA ligase, dU-glycosylase (when the non-replicable region is formed by abasic sites), a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during oligonucleotide attachment process), a DNA fragmentation endonuclease such as restriction enzyme(s), DNase I, Benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease; ATP; and dNTPs.
  • isothermal library synthesis/strand displacement-mediated amplification reaction it also comprises a nicking endonuclease (N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.); a strand displacing DNA polymerase (Klenow exo-, Phi 29, Bst I, etc.); and a primer.
  • nicking endonuclease N.AlwI, N.BbvCIA, N.BbvCIB, Nb.Bpu10I, Nb.BsmI, N.Bst9I, N.BstNBI, etc.
  • a strand displacing DNA polymerase Klenow exo-, Phi 29, Bst I, etc.
  • Exemplary pre-assembled Enz-O-Mix 7 may comprise all major components of the reaction, such as a stem-loop oligonucleotide; DNA polymerase; T4 DNA ligase; dU-glycosylase (when the hairpin non-replicable region is created by abasic sites); a hairpin-specific endonuclease (when the hairpin has a cleavable site created during oligonucleotide attachment process); a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I, Hpa II, Hpy 99I, Hpy CH4 IV, Hs
  • thermophilic DNA polymerase close-tube WMA library synthesis/PCR-mediated amplification reaction
  • ATP ATP
  • dNTPs dNTPs
  • Exemplary pre-assembled Enz-O-Mix 8 may comprise a stem-loop oligonucleotide with a promoter sequence in a stem or loop region; DNA polymerase; a DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during the oligonucleotide attachment process); a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I, Hpa II, Hpy
  • Exemplary pre-assembled Enz-O-Mix 9 may comprise a stem-loop oligonucleotide with a nicking endonuclease sequence in a stem or a loop region; DNA polymerase; a DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during oligonucleotide attachment process); a DNA fragmentation endonuclease, such as restriction enzyme(s), DNase I, Benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.; a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bs
  • Exemplary pre-assembled Enz-O-Mix 10 may comprise all major components of the reaction, such as a stem-loop oligonucleotide; DNA polymerase; a DNA ligase; dU-glycosylase (when the hairpin non-replicable region is created by abasic sites); a hairpin-specific endonuclease (when the hairpin has a cleavable site created during oligonucleotide attachment process); a DNA fragmentation endonuclease, such as restriction enzyme, DNase I, Benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.; a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, B
  • thermophilic DNA polymerase close-tube WGA library synthesis/PCR-mediated amplification reaction
  • ATP ATP
  • dNTPs dNTPs
  • Exemplary pre-assembled Enz-O-Mix 11 may comprise a stem-loop oligonucleotide with a promoter sequence in a stem or loop region; DNA polymerase; a DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during oligonucleotide attachment process); a DNA fragmentation endonuclease, such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease; a mixture of several (about 5-12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, B
  • Exemplary pre-assembled Enz-O-Mix 12 may comprise a stem-loop oligonucleotide with a nicking endonuclease sequence in a stem or a loop region; DNA polymerase; a DNA ligase; dU-glycosylase (when the non-replicable region is formed by abasic sites); a site-specific endonuclease (when the stem-loop oligonucleotide has a cleavable site created during oligonucleotide attachment process); a DNA fragmentation endonuclease, such as restriction enzyme(s), DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease; a mixture of several (about 5-about 12) methylation-sensitive restriction enzymes, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236
  • Kits comprising the exemplary Enz-O-Mixes described above may be supplied with the Enz-O-Mix Universal Buffer.
  • the Enz-O-Mix reagent is first diluted by the Enz-O-Mix Universal Buffer, aliquoted into microplate wells, pre-incubated at the reaction temperature (for example, about 37° C.) for a few minutes, supplemented with DNA, and incubated at the reaction temperature for about 1-about 16 h.
  • FIG. 20 demonstrates an exemplary application of the Enz-O-Mix kits for high-throughput library preparation/amplification in the 96- or 384-well format.
  • FIG. 21A illustrates the procedure for optimization of the Enz-O-Mix Universal Buffer.
  • Three specific but exemplary buffers are utilized, including Universal Buffers 1, 2 and 3.
  • Buffer 2 results in the early WGA amplification curve, suggesting that the multi-enzymatic reaction was more efficient in this buffer, and the Universal Buffer 2 is particularly suitable for the Enz-O-Mix reaction.
  • FIG. 21B illustrates the procedure for concentration optimization of the Enz-O-Mix incubation temperature.
  • Three temperatures are employed; specifically, T 1 , T 2 and T 3 .
  • Temperature T 3 results in the early WGA amplification curve, suggesting that the multi-enzymatic reaction was more efficient at this temperature and that the parameter T 3 should be selected as a more suitable condition for the Enz-O-Mix reaction.
  • FIG. 21C illustrates the procedure for optimization of the Enz-O-Mix component N.
  • Three concentrations of the component N specifically, C N 1 , C N 2 and C N 3 , were utilized.
  • Concentration C N 1 results in the early WGA amplification curve, suggesting that the multi-enzymatic reaction was more efficient at this component N concentration, and that the parameter C N 1 is a particularly suitable condition for the Enz-O-Mix reaction.
  • the applications of the Enz-O-Mix method are numerous.
  • the Enz-O-Mix method is easy to automate and use in clinical diagnostic and point-of-care applications. Different enzyme combinations could lead to many novel kits and assays, and applications in such areas as biotechnology, the pharmaceutical industry, molecular diagnostics, forensics, pathology, bio-defense, and bio-computing are contemplated
  • the Enz-O-Mix approach can be viewed as a simple and cost-effective alternative to the “lab-on-a chip” micro-fluidic approach that is currently attempting to solve the same problem (multi-step DNA processing) by reduction of reaction volumes and integration of multiple reactions into a small format.
  • Exemplary applications for the invention include but are not limited to the following:
  • DNA amplification and re-amplification can be used as an in vitro “immortalization” process to maintain and generate necessary quantities of valuable but limited DNA samples for gene association studies, mutation and microsatellite instability detection in cancer diagnostics, etc.
  • a single step WGA process is described wherein a partial hairpin oligonucleotide adaptor containing EcoNI recognition half sites in its stem is extended by a DNA polymerase to form a blunt end hairpin molecule and is ligated via its free 3′ end to the 5′ phosphate of blunt-ended DNA restriction fragments by T4 DNA ligase. Due to the strand-displacement activity of the DNA polymerase, the free 3′ end of the restriction fragments are extended using as template the ligated 3′ end of the adaptor, thus opening up the hairpin structure and generating functional EcoNI cleavage site ( FIGS. 12 and 13 A).
  • the DNA library molecules Following cleavage with EcoNI present in the same reaction mix, the DNA library molecules have their terminal inverted repeats excised and become amplifiable by PCR using a primer complementary to the 5′ stem portion of the adaptor sequence. The whole process takes place in a single tube and in one step in just about 1 hour, in specific embodiments.
  • the resulting library was amplified by real-time PCR in a reaction mixture containing: 1 ⁇ Titanium Taq reaction buffer (Clontech; Mountain View, Calif.); 200 ⁇ M each dNTP; 1:10,000 dilutions of fluorescein and SybrGreen I (Molecular Probes; Carlsbad, Calif.); 1 ⁇ M of K U primer (Table I, SEQ ID NO:2); and 5 units of Titanium Taq polymerase (Clontech; Mountain View, Calif.) in a reaction volume of 75 ⁇ l.
  • PCR amplification was carried out for 15 cycles at 95° C. for 15 sec and 65° C. for 2 min on i-Cycler real-time PCR instrument (Bio-Rad; Hercules, Calif.).
  • FIG. 22 shows the amplification curves of the libraries prepared in the presence or in the absence of EcoNI. Cleavage of the terminal inverted repeat by EcoNI improved the efficiency of amplification by 7 cycles, i.e. over two orders of
  • Preliminary representation analysis of the library prepared in the presence of EcoNI was conducted using three exemplary human genomic STS markers (Table II).
  • the material amplified by PCR with the universal Ku primer was purified with Qiaquick filters (Qiagen; Valencia, Calif.), and 20 ng aliquots were analyzed in real-time PCR. Reactions were carried out for 45 cycles at 94° C. for 15 sec and 68° C. for 1 min on i-Cycler (Bio-Rad; Hercules, Calif.).
  • the PCR reaction mixture comprised the following: 1 ⁇ Titanium Taq reaction buffer (Clontech; Mountain View, Calif.); 200 ⁇ M each dNTP; 1:10,000 dilutions of fluorescein and SybrGreen I (Molecular Probes); 0.2 ⁇ M each forward and reverse STS primer (Table II); 5 units of Titanium Taq polymerase (Clontech; Mountain View, Calif.); and 20 ng library DNA.
  • a control reaction comprising 1 ng of human genomic DNA randomly fragmented to an average size of 1.5 Kb using Hydro Shear device (Gene Machines; Palo Alto, Calif.) was performed.
  • FIGS. 24A-24C show unbiased representation of the analyzed human STS sequences in the EcoNI-treated library.
  • a single step WGA process is described wherein a hairpin oligonucleotide adaptor containing non-replicable 18-atom hexa-ethyleneglycol (HEG) spacer in its loop is ligated via its free 3′ end to the 5′ phosphate of DNA restriction fragments in the presence of T4 DNA ligase and a DNA polymerase. Due to the strand-displacement activity of the polymerase, the free 3′ ends of the restriction fragments are extended until the replication stop is reached (see FIGS. 8 and 10 A). This process results in truncated 3′ termini of the resulting WGA library such that they do not contain a terminal inverted repeat. The library molecules are then amplified by PCR using a primer complementary to the universal sequence of the extended 3′ termini. The whole process takes place in a single tube in one step and is completed in just about 1 hour, in specific embodiments.
  • HEG 18-atom hexa-ethyleneglycol
  • hairpin adaptor molecules that either do not comprise a replication stop or modified bases or that comprise ribo-nucleosides in their loop region are compared for their ability to participate in WGA along with the hexa-ethyleneglycol adaptor described above.
  • the resulting libraries were amplified by real-time PCR in a reaction mixture comprising the following: 1 ⁇ Titanium Taq reaction buffer (Clontech; Mountain View, Calif.); 200 ⁇ M each dNTP; 1:10,000 dilutions of fluorescein and SybrGreen I (Molecular Probes; Carlsbad, Calif.); 1 ⁇ M of universal primer (Y U primer, Table I SEQ ID NO:4 in the case of the HEG adaptor, or K U primer, Table 1, SEQ ID NO:2, in the case of control hairpin adaptors); and 5 units of Titanium Taq polymerase (Clontech; Mountain View, Calif.) in a reaction volume of 75 ⁇ l. PCR amplification was carried out at 95° C.
  • amplification of the library prepared by ligation of hexa-ethyleneglycol adaptor was 9 cycles more efficient than a library made with adaptor not containing a replication stop in its loop structure.
  • the results shown on FIG. 23 also indicate that an array of 5 consecutive ribonucleosides in the adaptor's loop is not a preferable replication stop for Klenow fragment of DNA polymerase I, since amplification of a library prepared by ligation of such an adaptor amplified only 2 cycles earlier than a library made with adaptor containing only deoxyribonucleosides.
  • FIGS. 24A-24C show unbiased representation of the analyzed human STS sequences in this exemplary library.
  • a hairpin oligonucleotide adaptor comprising deoxy-uridine in both its 5′ stem region and in its loop ( FIG. 10B ) is ligated via its free 3′ end to the 5′ phosphates of DNA restriction fragments in the presence of 3 enzymatic activities: T4 DNA ligase, DNA polymerase, and Uracil-DNA glycosylase (which is also referred to as UDG or dU glycosylase).
  • UDG catalyzes the release of free uracil and generates abasic sites in the adaptor's loop region and the 5′ half of the hairpin.
  • the strand-displacement activity of the DNA polymerase extends the free 3′ end of the restriction fragments until an abasic site is reached, serving as a replication stop ( FIG. 10B ).
  • This process results in truncated 3′ ends of the resulting WGA library fragments such that they do not have terminal inverted repeats.
  • samples Prior to amplification, samples are heated in order to break the phosphodiester bonds of the generated abasic sites, and the adaptor molecules are degraded into 2 small fragments and one intact 18 base oligonucleotide complementary to the universal sequence of the extended 3′ termini ( FIG. 10B ).
  • the released 18 base oligonucleotide then serves as a primer in subsequent PCR amplification, or alternatively it can be exogenously supplied.
  • the entire process takes place in a single tube in one step and is completed in just 1 hour.
  • the resulting library was amplified by real-time PCR in a reaction mixture comprising the following: 1 ⁇ Titanium Taq reaction buffer (Clontech, Mountain View, Calif.); 200 ⁇ M each dNTP; 1:10,000 dilutions of fluorescein and SybrGreen I (Molecular Probes; Carlsbad, Calif.); 1 ⁇ M of universal M U primer (Table I, SEQ ID NO:8); and 5 units of Titanium Taq polymerase (Clontech; in a reaction volume of 75 ⁇ l).
  • PCR amplifications were carried out at 95° C. for 15 sec and 65° C. for 2 min on i-Cycler real-time PCR instrument (Bio-Rad; Hercules, Calif.).
  • FIG. 25 shows that virtually identical amplification curves were generated whether or not the universal primer was added exogenously or was generated as a result of the UDG activity followed by heat-induced degradation of the adaptor.
  • FIG. 25 also shows that if UDG was not present during library preparation, this caused an 8 cycle-delay in amplification. This latter result once again indicates the preference of removal of the terminal inverted repeat of a hairpin adaptor for efficient library priming and amplification.
  • a single step WGA process is described wherein a hairpin oligonucleotide adaptor comprising deoxy-uridine described in Example 3 is ligated via its free 3′ end to the 5′ phosphates of DNA restriction fragments generated from intact genomic DNA in a single exemplary reaction mix comprising 4 exemplary enzymatic activities: AluI restriction endonuclease, T4 DNA ligase, DNA polymerase, and Uracil-DNA glycosylase (UDG) ( FIG. 19A , Enz-O-Mix 3).
  • UDG catalyses the release of free uracil and generates abasic sites in the adaptor's loop region and the 5′ half of the hairpin.
  • the resulting libraries were amplified by real-time PCR in the exemplary reaction mixture comprising the following: 1 ⁇ Titanium Taq reaction buffer (Clontech; Mountain View, Calif.); 200 ⁇ M each dNTP; 1:10,000 dilutions of fluorescein and SybrGreen I (Molecular Probes; Carlsbad, Calif.); 1 ⁇ M of universal M U primer (Table 1, SEQ ID NO:8); and 5 units of Titanium Taq polymerase (Clontech; Mountain View, Calif.) in a reaction volume of 75 ⁇ l. PCR amplifications were carried out at 95° C. for 15 sec and 65° C.
  • FIG. 26 shows the amplification curves of the resulting libraries. As shown, a series of titration curves was generated in a concentration-dependent manner. The smallest amount of DNA corresponding to less than two genome equivalents was still discernible from the control reaction with no DNA, indicating that the described single closed tube process is an efficient and sensitive way of whole genome amplification.
  • the preparation of methylome libraries from cell-free urine DNA by ligation of hairpin oligonucleotide adaptor comprising deoxy-uridine as described in Example 3 is combined with the simultaneous cleavage with a mix of methylation-sensitive restriction enzymes in a single step.
  • Cell-free DNA was isolated from urine of healthy donors collected in 50 ml Falcon tubes and stabilized for storage by adding 0.1 volume of 0.5 M EDTA. Urine samples were centrifuged at 1,800 ⁇ g for 10 min at ambient temperature to sediment cells, and supernatant was transferred carefully to a fresh tube. Equal volume of 6 M solution of guanidine thiocyanate was added to each sample followed by 1 ⁇ 6 vol of Wizard Miniprep resin (Promega catalog # A7141; Madison, Wis.). DNA was bound to the resin by rotation for 1 hour at ambient temperature.
  • the resin was then sedimented by brief centrifugation at 500 ⁇ g and loaded on Wizard minicolumns (Promega catalog #A7211; Madison, Wis.) using syringe barrel extensions after carefully decanting out the supernatant. Resin was washed with 5 ml of wash buffer (Promega catalog # A8102; Madison, Wis.) using Qiagen QIAvac-24 vacuum manifold. Minicolumns were then centrifuged for 2 min at 10,000 ⁇ g to remove residual wash buffer and bound DNA was eluted with 50 ⁇ l of DNAse-free water at 10,000 ⁇ g for 1 min. Eluted DNA was buffered by adding 0.1 vol of 10 ⁇ TE-L buffer and quantified on a fluorescent spectrophotometer using Pico Green (Molecular Probes; Carlsbad, Calif.) and I phage D.
  • Methylation analysis of promoter sites was performed by real-time PCR using aliquots of 160 ng of each digested or non-digested amplified library DNA incubated in exemplary reaction mixtures comprising the following: 1 ⁇ Titanium Taq reaction buffer (Clontech; Mountain View, Calif.); 200 ⁇ M of each dNTP; 4% DMSO; 0.5 M betaine; FCD (1:100,000) and SYBR Green I (1:100,000); 200 nM each forward and reverse primer (Table II, SEQ ID NO:11 and SEQ ID NO:12 for GSTP-1 promoter, SEQ ID NO:13 and SEQ ID NO:14 for MDR-1 promoter, SEQ ID NO:9 and SEQ ID NO:10 for EDNRB promoter, and SEQ ID NO:15 and SEQ ID NO:16 for PTGS-2 promoter); and approximately 1.5 units of Titanium Taq polymerase (Clontech; Mountain View, Calif.) in a final volume of 15 ⁇ l at 95° C. for
  • FIG. 27 shows PCR amplification curves of specific promoter sites in amplified libraries prepared from methylated (M) or non-methylated (N) urine DNA in the presence (+) or in the absence ( ⁇ ) of methylation-sensitive restriction enzymes.
  • M methylated
  • N non-methylated cleaved DNA
  • M ⁇ uncut DNA
  • M+ methylated DNA
  • GSTP-1 GGAAAGAGGGAAAGGCTTC (SEQ ID NO:11) Forward CCCCAGTGCTGAGTCACGG (SEQ ID NO:12) Reverse 11.
  • MDR-1 GGGTGGGAGGAAGCATCGTC (SEQ ID NO:13) Forward GGTCTCCAGCATCTCCACGAA (SEQ ID NO:14) Reverse 12.
  • PTGS-2 AGAACTGGCTCTCGGAAGCG (SEQ ID NO:15) Forward GGGAGCAGAGGGGGTAGTC (SEQ ID NO:16) Reverse 13.
  • This example demonstrates an exemplary preparation of a library from lambda phage BstEII restriction digest by ligation of hairpin oligonucleotide adaptor comprising deoxy-uridine and T7 promoter sequence combined with the simultaneous isothermal amplification by in vitro transcription with T7 RNA polymerase (see FIG. 6A and FIG. 19A , Enz-O-Mix 2).
  • the adaptor oligonucleotide used in this example (Table 1, SEQ ID NO:9) is based on the adaptor sequence described in Example 3 (Table I, SEQ ID NO:8), except that it has the consensus T7 phage promoter sequence incorporated in the loop region.
  • T4 DNA ligase creates abasic sites by destabilizing the 5′ end of the adaptor stem.
  • T4 DNA polymerase generates blunt ends at the restriction fragments leaving intact 5′ phosphate groups that are necessary for ligation to the free 3′ end of the adaptor by the T4 DNA ligase.
  • T4 DNA polymerase then extends the 3′ ends of the newly ligated restriction fragments into the adaptor, thereby displacing the 5′ end of the adaptor's stem until an abasic site created by UDG is reached that stops further extension. By doing so, the T4 DNA polymerase generates a fully functional double-stranded T7 promoter, and in vitro transcription is initiated by T7 RNA polymerase.
  • FIG. 28 shows the products of an exemplary in vitro transcription amplification. As shown, in the presence of all four enzymatic activities the lambda restriction fragments are converted into a library amplified as RNA products, whereas in the absence of T4 DNA ligase no accumulation of RNA occurs. This demonstrates that library preparation and isothermal amplification can be combined into a single-step process.
  • FIG. 29 This embodiment is illustrated in FIG. 29 and describes the one-step Enz-O-Mix attachment process for a stem-loop oligonucleotide with a non-replicable linker that is accompanied by immobilization of the synthesized library to the surface of a vessel where the reaction occurs (for example, a tube, micro-plate well, glass slide, micro-beads, etc.).
  • the exemplary reaction mix comprises HMW DNA; a stem-loop oligonucleotide with 3′ recessed, 3′ protruding or blunt end ( FIG.
  • a DNA fragmentation endonuclease such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.
  • a DNA fragmentation endonuclease such as restriction enzyme, DNase I, benzonase, methylation-specific nuclease McrBC, apoptotic endonuclease, etc.
  • a 3′ proofreading DNA polymerase Klenow fragment of the DNA polymerase I, T4 DNA polymerase, etc.
  • T4 DNA ligase Enz-O-Mix Universal Buffer
  • ATP ATP
  • dNTPs dNTPs.
  • the reaction occurs inside a tube or a micro-plate well containing a hybridization-capture oligonucleotide (HCO) covalently attached to the inner surface of the reaction vessel.
  • HCO hybridization-capture oligonucleotide
  • Oligonucleotide HCO has a sequence that is complementary to a portion of the stem-loop oligonucleotide located between the 5′ end and the non-replicable linker.
  • Library immobilization can be non-covalent (as shown on FIG. 29A ), or covalent (as shown on FIG. 29B ).
  • the first case (non-covalent immobilization) relies solely on the hybridization between the 5′ overhang (produced from the stem-loop oligonucleotide during its ligation to DNA ends and subsequent replication) and the capture oligo HCO.
  • the second case (covalent immobilization) involves hybridization as an initial step, but it also involves additional enzymatic steps, such as site-specific cleavage within the single stranded 5′ overhang and ligation of the 5′ end of DNA to the ligation-capture oligonucleotide construct LCO.
  • the purpose of the cleavage reaction is to generate a 5′ phosphate group for the ligation reaction.
  • Such cleavage can be achieved, for example, by incubation with the USER enzyme (a mixture of Uracil DNA glycosylase (UDG) and the DNA glycosylase-lyase Endonuclease VIII; New England Biolabs, Beverly, Mass.).
  • UDG catalyses the excision of a uracil base (located somewhere at the 5′ portion of the stem-loop oligonucleotide), forming an abasic (apyrimidinic) site while leaving the phosphodiester backbone intact.
  • Endonuclease VIII breaks the phosphodiester backbone at the 3′ and 5′ sides of the abasic site leaving a 5′ phosphate.
  • a generated phosphate group at the end of the 5′ overhang is then ligated by a DNA ligase to the 3′ end of the ligation-capture oligonucleotide construct LCO (see FIG. 29B ).
  • the synthesized and surface-immobilized Whole Genome Library (as described above), or Whole Methylome Library (if the methylation-sensitive restriction nucleases, such as Aci I, Acc II, Asp LE I, Ava I, Bce AI, Bsa HI, Bsh 1236 I, Bsi E1, Bsi SI, Bst FN I, Bst HH I, Bst UI, Cfo I, Hap II, Hga I, Hha I, HinP1 I, Hin 6I, Hpa II, Hpy 99I, Hpy CH4 IV, Hsp AI, Mvn I, and Ssi I, or the methylation-specific nucleases, such as McrBC, are included into the Enz-O-Mix or used after the library synthesis) can be further processed enzymatically, washed, and amplified or stored in an immobilized format.
  • the methylation-sensitive restriction nucleases such as Aci I, Acc
  • FIG. 31 illustrates a specific but exemplary use of the one-step library synthesis and immobilization in a hypothetical fluidic device.
  • the process starts by a library synthesis (I), is continued by a library immobilization at the bottom of a reaction vessel (II), and is completed by removal of the first reagent mix, washing, and introduction of a new reagent mix (for example, PCR components).
  • a library synthesis I
  • II a library immobilization at the bottom of a reaction vessel
  • a new reagent mix for example, PCR components
  • This example demonstrates an exemplary preparation of a library from cell-free urine DNA by ligation of hairpin oligonucleotide adaptor comprising deoxy-uridine and N.BbvC IB nicking endonuclease recognition site located at the loop region as illustrated in FIG. 16A followed by isothermal amplification with a strand-displacing DNA polymerase (see FIG. 6A and FIG. 19A , Enz-O-Mix 3).
  • the adaptor oligonucleotide used in this example (Table I, SEQ ID NO:18) is based on the adaptor sequence described in Example 3 (Table I, SEQ ID NO:8), except that it has recognition sequence 5′-CCTCAGC-3′ for N.BbvC IB nicking endonuclease in the loop region.
  • a stem-loop adaptor attachment is accomplished by using a mix ( FIG. 18 , Master Mix III) with 3 enzymatic activities: T4 DNA ligase, T4 DNA polymerase, and Uracil-DNA glycosylase.
  • UDG creates abasic sites by destabilizing the 5′ end of the adaptor stem.
  • T4 DNA polymerase generates blunt ends at the restriction fragments leaving intact 5′ phosphate groups that are necessary for ligation to the free 3 end of the adaptor by the T4 DNA ligase.
  • T4 DNA polymerase then extends the 3′ ends of the newly ligated restriction fragments into the adaptor, thereby displacing the 5′ end of the adaptor's stem until an abasic site generated by UDG is reached that stops further extension. By doing so, the T4 DNA polymerase generates a functional double-stranded N.BbvC IB nicking endonuclease recognition site.
  • the mix is supplemented with two additional enzymatic activities, N.BbvC IB nicking endonuclease generating single-stranded nicks at the adaptor (and internal) sites, and the strand-displacing Klenow fragment of DNA polymerase I, initiating strand displacement from the nicks.
  • the newly synthesized strand is extended until a nick or abasic site at the template strand is encountered.
  • an oligonucleotide primer comprising the adaptor's loop sequence at its 5′-end plus five bases complementary to the adaptor's stem at its 3′-end (Table I, SEQ ID NO:19) is also added to the mix. As a result, a self-sustained isothermal DNA amplification process is accomplished.
  • Cell-free DNA was isolated from urine of healthy donors as described in Example 5. Aliquots of 50 nanograms of DNA were incubated in 1 ⁇ NEBuffer 4 (New England Biolabs; Beverly, Mass.) with 2 ⁇ M adaptor oligonucleotide comprising deoxy-uridine and N.BbvC IB nicking endonuclease recognition site (Table I, SEQ ID NO:18); 1 mM ATP; 40 ⁇ M each dNTP; 200 ⁇ g/ml BSA; 1 unit of uracil-DNA glycosylase (New England Biolabs; Beverly, Mass.); 0.18 unit of T4 DNA polymerase (New England Biolabs; Beverly, Mass.); and 600 units of T4 DNA ligase (New England Biolabs; Beverly, Mass.) for 1 hour at 37° C.
  • FIG. 29 shows the products of an exemplary isothermal DNA amplification after 1 hour incubation. As shown, in the presence of all five enzymatic activities the lambda restriction fragments are converted into a library amplified as DNA products, whereas in the absence of T4 DNA ligase or N.BbvC IB nicking endonuclease no accumulation of DNA occurs.
  • Enz-O-Mix library synthesis/amplification is performed in two operational steps: step 1 —a tube containing DNA is supplemented with the library (WGA or WMA) synthesis reagents and incubated at 37° C. for 1 h, and step 2 —a tube is opened, supplemented with PCR amplification buffer/reagents and subjected to temperature cycling.
  • step 1 a tube containing DNA is supplemented with the library (WGA or WMA) synthesis reagents and incubated at 37° C. for 1 h
  • step 2 a tube is opened, supplemented with PCR amplification buffer/reagents and subjected to temperature cycling.
  • This example introduces further simplification in preparation and PCR-mediated amplification of WGA/WMA libraries when all the necessary synthesis/amplification reagents are introduced into the tube prior reaction, and library synthesis and subsequent amplification occur in the same volume and the same buffer without opening the tube within a pre-programmed thermocycler ( FIG. 30B ).
  • Such an approach is referred to herein as an integrated, one-step, closed-tube protocol. Due to its simplicity and lack of any human intervention, the integrated, one-step, closed-tube Enz-O-Mix DNA amplification can be easily automated and used for high-throughput research applications and clinical diagnostics.
  • FIG. 31 shows a one possible temperature profile (b) and an envisioned DNA accumulation during amplification (a), where incubation at 37° C. for 1 h (DNA library synthesis) is followed by heating at 95° C. for 10 min (Taq DNA polymerase activation and stem-loop adaptor ⁇ universal PCR primer conversion), and then by thermocycling between 65° C. and 95° C. for 1 h (PCR-mediated whole genome or whole methylome amplification).
  • FIG. 32 shows biochemical and physicochemical reactions involved in the transformation of the stem-loop adaptor oligonucleotide into a functional universal PCR primer adequate for efficient amplification of synthesized WGA/WMA libraries.
  • Dual utilization of the stem-loop oligonucleotide as adaptor and PCR primer eliminate a necessity to introduce into reaction an additional single stranded oligo-primer (due to the 3′ proofreading activity of a DNA polymerase involved in the library synthesis process such primer should contain at least several nuclease-resistant bases at its 3′ terminus).
  • a WGA process is described wherein a hairpin oligonucleotide adaptor comprising deoxy-uridine described in Example 3 is ligated via its free 3′ end to the 5′ phosphates of DNA restriction fragments generated from intact genomic DNA in a single enclosed container exemplary reaction mix comprising 6 exemplary enzymatic activities: AluI restriction endonuclease, RsaI restriction endonuclease, T4 DNA ligase, T4 DNA polymerase, a hot-start Taq DNA polymerase, and Uracil-DNA glycosylase (UDG).
  • UDG catalyses the release of free uracil and generates abasic sites in the adaptor's loop region and the 5′ half of the hairpin.
  • AluI and RsaI digest the target DNA into restriction fragments.
  • T4 DNA polymerase generates blunt ends of the restriction fragments.
  • T4 DNA ligase generates a phosphodiester bond between the 3′ ends of the adaptor molecules and the 5′ phosphates of the restriction fragments.
  • T4 DNA polymerase extends the free 3′ end of the restriction fragments using as template the ligated 3′ end of the hairpin stem until an abasic site is reached that serves as a replication stop ( FIG. 10B ). Samples are heated to 72° C.
  • thermo-labile enzymes to inactivate all thermo-labile enzymes and to activate Taq polymerase, then to 95° C. to degrade the abasic sites of the adaptor and to generate active primer from the remaining intact strand of the adaptor that is free of abasic sites.
  • the resulting library is finally amplified by thermal cycling. The entire process takes place in a single enclosed reaction container under programmed temperature control algorithm and without any intermediate liquid handling.
  • Mg ++ concentrations of 5 mM and 7.5 mM in the reaction buffer supported the enzymatic activities present in the mix better than the basic Titanium Taq buffer containing 3.5 mM MgCl 2 .
  • the presence of 4% DMSO did not have significant effect on the WGA amplification when higher Mg ++ concentrations were applied.
  • Hot start PCR protocol was introduced to reduce the non-specific primer/template and primer/primer annealing events that occur at lower temperatures and subsequently result in non-specific amplification products.
  • Several methods and corresponding commercial products for performing hot start PCR rely upon the physical separation of PCR reagents until the high temperature of the reaction has been reached. Those products include the following:
  • Wax beads (Ampliwax PCR Gems, Perkin Elmer) that create a temporary barrier between dNTPs, buffer, and MgCl 2 on one side of the wax layer, and DNA template and DNA polymerase on another side.
  • Example 9 introduced the idea of using a degradable, dU-containing stem-loop oligonucleotide-adaptor as a universal PCR primer (see FIG. 32 ) for whole genome amplification.
  • This embodiment extends the use of degradable, dU-containing stem-loop oligonucleotides as “hot start” PCR primers for locus-specific DNA amplification.
  • both PCR primers are synthesized in a form of stem-loop oligonucleotides A and B.
  • the 3′ portion of the stem-loop oligonucleotides represents the primer sequence (no dU bases); the 5′ portion represents the sequence complementary to the primer sequence and comprises one or more dU bases substituting dT bases; and the loop comprises several dT and dU bases.
  • thermocycler is programmed to have the following conditions:
  • the conversion of the stem-loop oligonucleotides A and B into PCR primers A and B results from several breaks introduced by heating the loop and the 5′ portion of the oligonucleotides.
  • the small oligonucleotides originated from the 5′ stem regions can not form stable interaction with the remaining intact 3′ primer regions and do not affect the PCR process.
  • the position of dU bases within the 5′ stem region is dictated by the location of thymines in a DNA sequence, although they can be also introduced at another nucleotide position (thus generating a stem with one or several mismatched bases).
  • the number of dU bases within the 5′ stem and the loop regions can vary from 1 to about 6, and an optimal number can be determined empirically.
  • the proposed hot start primer method can be used in PCR and other DNA/RNA amplification methods that utilize thermostable polymerases. It has several advantages over the hot start PCR methods that involve either non-degradable hairpin primers with short stem [Kaboev, O.
  • duplex primers [Kong, D., et al., 2004]: a) the hybridization kinetics are not compromised by the presence of a stem region (as it might be in the case of non-degradable stem-loop primer method); b) no inverted repeat is formed at the ends of PCR amplicons that could substantially reduce the efficiency of the PCR amplification process (as it happens in the case of non-degradable stem-loop primer method); and c) oligonucleotides complementary to the priming oligonucleotide (products of the stem-loop oligonucleotide fragmentation) are short, do not form stable interaction with the remaining intact 3′ primer regions and, as a result, do not affect the PCR process (as it possible in the duplex primer method).
  • thermostable DNA polymerase Advantages over other existing hot-start methods include but are not limited to the following: a) no phase separation is necessary and all reaction components are originally present in the same reaction mix simplifying storage and reducing production cost; b) no expensive blocking antibodies are involved; c) no mutagenesis or chemical modification of amino acid residues in the thermostable DNA polymerase are required whatsoever.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
US11/366,222 2005-08-02 2006-03-02 Compositions and methods for processing and amplification of DNA, including using multiple enzymes in a single reaction Abandoned US20070031857A1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US11/366,222 US20070031857A1 (en) 2005-08-02 2006-03-02 Compositions and methods for processing and amplification of DNA, including using multiple enzymes in a single reaction
US12/270,850 US7803550B2 (en) 2005-08-02 2008-11-13 Methods of producing nucleic acid molecules comprising stem loop oligonucleotides
US12/892,359 US8071312B2 (en) 2005-08-02 2010-09-28 Methods for producing and using stem-loop oligonucleotides
US13/286,937 US8399199B2 (en) 2005-08-02 2011-11-01 Use of stem-loop oligonucleotides in the preparation of nucleic acid molecules
US13/766,607 US8728737B2 (en) 2005-08-02 2013-02-13 Attaching a stem-loop oligonucleotide to a double stranded DNA molecule
US14/250,538 US9598727B2 (en) 2005-08-02 2014-04-11 Methods for processing and amplifying nucleic acids
US15/430,803 US10196686B2 (en) 2005-08-02 2017-02-13 Kits including stem-loop oligonucleotides for use in preparing nucleic acid molecules
US15/674,468 US10208337B2 (en) 2005-08-02 2017-08-10 Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US16/231,002 US11072823B2 (en) 2005-08-02 2018-12-21 Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US17/326,844 US20210292828A1 (en) 2005-08-02 2021-05-21 Compositions Including A Double Stranded Nucleic Acid Molecule And A Stem-Loop Oligonucleotide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70493205P 2005-08-02 2005-08-02
US11/366,222 US20070031857A1 (en) 2005-08-02 2006-03-02 Compositions and methods for processing and amplification of DNA, including using multiple enzymes in a single reaction

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/270,850 Continuation US7803550B2 (en) 2005-08-02 2008-11-13 Methods of producing nucleic acid molecules comprising stem loop oligonucleotides

Publications (1)

Publication Number Publication Date
US20070031857A1 true US20070031857A1 (en) 2007-02-08

Family

ID=36754076

Family Applications (10)

Application Number Title Priority Date Filing Date
US11/366,222 Abandoned US20070031857A1 (en) 2005-08-02 2006-03-02 Compositions and methods for processing and amplification of DNA, including using multiple enzymes in a single reaction
US12/270,850 Active US7803550B2 (en) 2005-08-02 2008-11-13 Methods of producing nucleic acid molecules comprising stem loop oligonucleotides
US12/892,359 Active US8071312B2 (en) 2005-08-02 2010-09-28 Methods for producing and using stem-loop oligonucleotides
US13/286,937 Expired - Fee Related US8399199B2 (en) 2005-08-02 2011-11-01 Use of stem-loop oligonucleotides in the preparation of nucleic acid molecules
US13/766,607 Active US8728737B2 (en) 2005-08-02 2013-02-13 Attaching a stem-loop oligonucleotide to a double stranded DNA molecule
US14/250,538 Expired - Fee Related US9598727B2 (en) 2005-08-02 2014-04-11 Methods for processing and amplifying nucleic acids
US15/430,803 Active US10196686B2 (en) 2005-08-02 2017-02-13 Kits including stem-loop oligonucleotides for use in preparing nucleic acid molecules
US15/674,468 Active US10208337B2 (en) 2005-08-02 2017-08-10 Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US16/231,002 Active 2026-11-20 US11072823B2 (en) 2005-08-02 2018-12-21 Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US17/326,844 Abandoned US20210292828A1 (en) 2005-08-02 2021-05-21 Compositions Including A Double Stranded Nucleic Acid Molecule And A Stem-Loop Oligonucleotide

Family Applications After (9)

Application Number Title Priority Date Filing Date
US12/270,850 Active US7803550B2 (en) 2005-08-02 2008-11-13 Methods of producing nucleic acid molecules comprising stem loop oligonucleotides
US12/892,359 Active US8071312B2 (en) 2005-08-02 2010-09-28 Methods for producing and using stem-loop oligonucleotides
US13/286,937 Expired - Fee Related US8399199B2 (en) 2005-08-02 2011-11-01 Use of stem-loop oligonucleotides in the preparation of nucleic acid molecules
US13/766,607 Active US8728737B2 (en) 2005-08-02 2013-02-13 Attaching a stem-loop oligonucleotide to a double stranded DNA molecule
US14/250,538 Expired - Fee Related US9598727B2 (en) 2005-08-02 2014-04-11 Methods for processing and amplifying nucleic acids
US15/430,803 Active US10196686B2 (en) 2005-08-02 2017-02-13 Kits including stem-loop oligonucleotides for use in preparing nucleic acid molecules
US15/674,468 Active US10208337B2 (en) 2005-08-02 2017-08-10 Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US16/231,002 Active 2026-11-20 US11072823B2 (en) 2005-08-02 2018-12-21 Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
US17/326,844 Abandoned US20210292828A1 (en) 2005-08-02 2021-05-21 Compositions Including A Double Stranded Nucleic Acid Molecule And A Stem-Loop Oligonucleotide

Country Status (5)

Country Link
US (10) US20070031857A1 (fr)
EP (1) EP1924704B1 (fr)
AT (1) ATE510930T1 (fr)
DK (1) DK1924704T3 (fr)
WO (1) WO2007018601A1 (fr)

Cited By (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060166250A1 (en) * 2005-01-25 2006-07-27 Sydney Brenner Isothermal DNA amplification
US20070190556A1 (en) * 2006-01-23 2007-08-16 Sydney Brenner Selective genome amplification
US20090017453A1 (en) * 2007-07-14 2009-01-15 Maples Brian K Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US20090098612A1 (en) * 2007-10-11 2009-04-16 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
JP2009225682A (ja) * 2008-03-19 2009-10-08 National Institute Of Agrobiological Sciences 外来ｄｎａ断片由来の逆方向反復配列を含む組換えベクター及びその作製方法
WO2010030683A1 (fr) * 2008-09-09 2010-03-18 Rosetta Inpharmatics Llc Procédés de génération de bibliothèques spécifiques de gènes
US20110105364A1 (en) * 2009-11-02 2011-05-05 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence selection and amplification
US20110319290A1 (en) * 2010-06-08 2011-12-29 Nugen Technologies, Inc. Methods and Compositions for Multiplex Sequencing
WO2012061036A1 (fr) * 2010-11-03 2012-05-10 Illumina, Inc. Réduction de la formation de dimères adaptères
US20130045885A1 (en) * 2010-02-18 2013-02-21 Univeristy Of South Florida Materials and methods for profiling micrornas
US20130230887A1 (en) * 2011-09-01 2013-09-05 New England Biolabs, Inc. Synthetic Nucleic Acids for Polymerization Reactions
US20140030704A1 (en) * 2008-04-30 2014-01-30 Population Genetics Technologies Ltd Asymmetric Adapter Library Construction
US20140134610A1 (en) * 2012-01-31 2014-05-15 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
US20140256568A1 (en) * 2011-06-02 2014-09-11 Raindance Technologies, Inc. Sample multiplexing
WO2014160059A1 (fr) * 2013-03-13 2014-10-02 Gen9, Inc. Compositions et procédés pour la synthèse d'oligonucléotides à fidélité élevée
US20150080241A1 (en) * 2013-09-16 2015-03-19 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US20150105275A1 (en) * 2012-11-02 2015-04-16 Life Technologies Corporation Small RNA Capture, Detection and Quantification
US9109222B2 (en) * 2010-12-27 2015-08-18 Ibis Biosciences, Inc. Nucleic acid sample preparation methods and compositions
CN105121664A (zh) * 2013-02-20 2015-12-02 埃默里大学 混合物及其相关组合物中的核酸的测序方法
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
WO2015200541A1 (fr) 2014-06-24 2015-12-30 Bio-Rad Laboratories, Inc. "barcoding" par pcr numérique
US9352312B2 (en) 2011-09-23 2016-05-31 Alere Switzerland Gmbh System and apparatus for reactions
US9376711B2 (en) 2011-07-13 2016-06-28 Qiagen Mansfield, Inc. Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample
US9403141B2 (en) 2013-08-05 2016-08-02 Twist Bioscience Corporation De novo synthesized gene libraries
US9493825B2 (en) 2011-03-18 2016-11-15 University Of South Florida Materials and methods for profiling microRNAs
WO2016195963A1 (fr) * 2015-05-29 2016-12-08 Tsavachidou Dimitra Procédés de construction de copies de molécules d'acide nucléique reliées de façon consécutive
US9650628B2 (en) 2012-01-26 2017-05-16 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library regeneration
US9677067B2 (en) 2015-02-04 2017-06-13 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
US20170240955A1 (en) * 2014-10-14 2017-08-24 Oxford Nanopore Technologies Ltd. Method
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
US9895673B2 (en) 2015-12-01 2018-02-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
US9957549B2 (en) 2012-06-18 2018-05-01 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US9981239B2 (en) 2015-04-21 2018-05-29 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
CN108138209A (zh) * 2015-08-12 2018-06-08 环基因治疗诊断有限责任公司 通过原位扩增制备细胞游离核酸分子的方法
US10017809B2 (en) 2013-03-15 2018-07-10 Theranos Ip Company, Llc Nucleic acid amplification
US20180208966A1 (en) * 2015-07-17 2018-07-26 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Cloning of single-stranded nucleic acid
US10053688B2 (en) 2016-08-22 2018-08-21 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
US10131939B2 (en) 2013-03-15 2018-11-20 Theranos Ip Company, Llc Nucleic acid amplification
US20190153535A1 (en) * 2010-10-22 2019-05-23 Cold Spring Harbor Laboratory Varietal counting of nucleic acids for obtaining genomic copy number information
US10417457B2 (en) 2016-09-21 2019-09-17 Twist Bioscience Corporation Nucleic acid based data storage
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
US10501767B2 (en) 2013-08-16 2019-12-10 Oxford Nanopore Technologies Ltd. Polynucleotide modification methods
CN110760579A (zh) * 2018-10-10 2020-02-07 杭州翱锐基因科技有限公司 扩增游离dna的试剂以及扩增方法
US10563250B2 (en) 2015-03-13 2020-02-18 Life Technologies Corporation Methods, compositions and kits for small RNA capture, detection and quantification
US10570448B2 (en) 2013-11-13 2020-02-25 Tecan Genomics Compositions and methods for identification of a duplicate sequencing read
US10597713B2 (en) 2011-07-25 2020-03-24 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US10669304B2 (en) 2015-02-04 2020-06-02 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
US10669578B2 (en) 2014-02-21 2020-06-02 Oxford Nanopore Technologies Ltd. Sample preparation method
US10696965B2 (en) 2017-06-12 2020-06-30 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US10711309B2 (en) 2005-11-26 2020-07-14 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10731220B2 (en) 2010-05-18 2020-08-04 Natera, Inc. Methods for simultaneous amplification of target loci
US10774380B2 (en) 2010-05-18 2020-09-15 Natera, Inc. Methods for multiplex PCR amplification of target loci in a nucleic acid sample
US10844373B2 (en) 2015-09-18 2020-11-24 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
US10876160B2 (en) * 2011-10-31 2020-12-29 Eiken Kagaku Kabushiki Kaisha Method for detecting target nucleic acid
US10894980B2 (en) * 2015-07-17 2021-01-19 President And Fellows Of Harvard College Methods of amplifying nucleic acid sequences mediated by transposase/transposon DNA complexes
US10894242B2 (en) 2017-10-20 2021-01-19 Twist Bioscience Corporation Heated nanowells for polynucleotide synthesis
US10894959B2 (en) 2017-03-15 2021-01-19 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
US10907274B2 (en) 2016-12-16 2021-02-02 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
US10936953B2 (en) 2018-01-04 2021-03-02 Twist Bioscience Corporation DNA-based digital information storage with sidewall electrodes
US11028430B2 (en) 2012-07-09 2021-06-08 Nugen Technologies, Inc. Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US20210189382A1 (en) * 2012-11-05 2021-06-24 Takara Bio Usa, Inc. Barcoding Nucleic Acids
US20210198733A1 (en) 2018-07-03 2021-07-01 Natera, Inc. Methods for detection of donor-derived cell-free dna
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11149303B2 (en) * 2012-09-13 2021-10-19 Takara Bio Usa, Inc. Methods of depleting a target nucleic acid in a sample and kits for practicing the same
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
US20210340598A1 (en) * 2016-12-14 2021-11-04 Codex Dna, Inc. Methods for assembling dna molecules
US11254960B2 (en) 2013-03-15 2022-02-22 Labrador Diagnostics Llc Nucleic acid amplification
US11286530B2 (en) 2010-05-18 2022-03-29 Natera, Inc. Methods for simultaneous amplification of target loci
US11306357B2 (en) 2010-05-18 2022-04-19 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11319596B2 (en) 2014-04-21 2022-05-03 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11332738B2 (en) 2019-06-21 2022-05-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11352664B2 (en) 2009-01-30 2022-06-07 Oxford Nanopore Technologies Plc Adaptors for nucleic acid constructs in transmembrane sequencing
US11377676B2 (en) 2017-06-12 2022-07-05 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US11390916B2 (en) 2014-04-21 2022-07-19 Natera, Inc. Methods for simultaneous amplification of target loci
US11407837B2 (en) 2017-09-11 2022-08-09 Twist Bioscience Corporation GPCR binding proteins and synthesis thereof
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US11492728B2 (en) 2019-02-26 2022-11-08 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
US11492665B2 (en) 2018-05-18 2022-11-08 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
US11492727B2 (en) 2019-02-26 2022-11-08 Twist Bioscience Corporation Variant nucleic acid libraries for GLP1 receptor
US11512347B2 (en) 2015-09-22 2022-11-29 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
US11519028B2 (en) 2016-12-07 2022-12-06 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US11550939B2 (en) 2017-02-22 2023-01-10 Twist Bioscience Corporation Nucleic acid based data storage using enzymatic bioencryption
US11560589B2 (en) 2013-03-08 2023-01-24 Oxford Nanopore Technologies Plc Enzyme stalling method
US11629377B2 (en) 2017-09-29 2023-04-18 Evonetix Ltd Error detection during hybridisation of target double-stranded nucleic acid
US11649480B2 (en) 2016-05-25 2023-05-16 Oxford Nanopore Technologies Plc Method for modifying a template double stranded polynucleotide
US11667952B2 (en) 2017-08-24 2023-06-06 Takara Bio Usa, Inc. Methods of producing nucleic acids using oligonucleotides modified by a stimulus
US11702662B2 (en) * 2011-08-26 2023-07-18 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
US11725205B2 (en) 2018-05-14 2023-08-15 Oxford Nanopore Technologies Plc Methods and polynucleotides for amplifying a target polynucleotide
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US12020778B2 (en) 2010-05-18 2024-06-25 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12091777B2 (en) 2019-09-23 2024-09-17 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2
US12100478B2 (en) 2012-08-17 2024-09-24 Natera, Inc. Method for non-invasive prenatal testing using parental mosaicism data
US12146195B2 (en) 2016-04-15 2024-11-19 Natera, Inc. Methods for lung cancer detection
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12173282B2 (en) 2019-09-23 2024-12-24 Twist Bioscience, Inc. Antibodies that bind CD3 epsilon
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12260934B2 (en) 2014-06-05 2025-03-25 Natera, Inc. Systems and methods for detection of aneuploidy
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
US12357959B2 (en) 2018-12-26 2025-07-15 Twist Bioscience Corporation Highly accurate de novo polynucleotide synthesis
US12460264B2 (en) 2016-11-02 2025-11-04 Natera, Inc. Method of detecting tumour recurrence
US12492430B2 (en) 2017-04-11 2025-12-09 Tecan Genomics, Inc. Library quantitation and qualification
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2235179B1 (fr) * 2007-12-24 2017-11-15 BerGenBio ASA Procédés pour créer et identifier des éléments d'interférence avec des arn fonctionnels
WO2011001274A2 (fr) 2009-07-02 2011-01-06 Nucleix Procédés pour faire une distinction entre des échantillons d’adn naturels et artificiels
ES2562159T3 (es) 2009-08-20 2016-03-02 Population Genetics Technologies Ltd. Composiciones y métodos para el reordenamiento de ácido nucleico molecular
WO2011101728A2 (fr) * 2010-02-19 2011-08-25 Nucleix Identification de source d'échantillons d'adn
US9752187B2 (en) * 2009-12-11 2017-09-05 Nucleix Categorization of DNA samples
US8574832B2 (en) * 2010-02-03 2013-11-05 Massachusetts Institute Of Technology Methods for preparing sequencing libraries
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
JP5851496B2 (ja) * 2010-06-14 2016-02-03 ナショナル ユニヴァーシティー オブ シンガポール 修飾ステムループオリゴヌクレオチドが仲介する逆転写および塩基間隔が制限された定量的ｐｃｒ
BR112013004044A2 (pt) 2010-08-13 2016-07-05 Envirologix Inc composições e métodos para quantificação de uma sequência de ácido nucleico em uma amostra.
WO2012103154A1 (fr) * 2011-01-24 2012-08-02 Nugen Technologies, Inc. Amorces/adaptateurs arn/adn composites à boucle-tige : compositions et méthodes de génération de bibliothèques, d'amplification et autres manipulations en aval
US20150315597A1 (en) * 2011-09-01 2015-11-05 New England Biolabs, Inc. Synthetic Nucleic Acids for Polymerization Reactions
GB201119904D0 (en) * 2011-11-17 2011-12-28 Univ Vilnius Analysis of methylation sites
CN114134207A (zh) 2012-04-09 2022-03-04 一龙公司 用于量化样品中核酸序列的组合物和方法
US9777319B2 (en) 2012-06-29 2017-10-03 General Electric Company Method for isothermal DNA amplification starting from an RNA template
EP4397767A3 (fr) 2012-08-14 2024-07-31 10X Genomics, Inc. Compositions de microcapsules et procédés
US10400280B2 (en) 2012-08-14 2019-09-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2014093676A1 (fr) 2012-12-14 2014-06-19 10X Technologies, Inc. Procédés et systèmes pour le traitement de polynucléotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US20140170667A1 (en) * 2012-12-19 2014-06-19 Nanomr, Inc. Methods for amplifying nucleic acid from a target
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9128861B2 (en) 2013-01-17 2015-09-08 Personalis, Inc. Methods and systems for genetic analysis
WO2014124336A2 (fr) 2013-02-08 2014-08-14 10X Technologies, Inc. Fractionnement et traitement d'analytes et d'autres espèces
US9708658B2 (en) 2013-03-19 2017-07-18 New England Biolabs, Inc. Enrichment of target sequences
KR101503726B1 (ko) 2013-04-30 2015-03-19 (주)진매트릭스 Ｄｎａ 제한효소에 의해 활성 조절이 가능한 프라이머 및 이를 이용한 유전자 증폭방법 그리고 이러한 프라이머의 설계방법
US10155977B2 (en) * 2013-08-09 2018-12-18 Genebio Systems, Inc. DNA amplification via scissor-like structures (DASL)
US10395758B2 (en) 2013-08-30 2019-08-27 10X Genomics, Inc. Sequencing methods
WO2015031689A1 (fr) 2013-08-30 2015-03-05 Personalis, Inc. Méthodes et systèmes d'analyse génomique
WO2015051275A1 (fr) 2013-10-03 2015-04-09 Personalis, Inc. Procédés d'analyse de génotypes
US10287622B2 (en) 2013-11-07 2019-05-14 Agilent Technologies, Inc. Plurality of transposase adapters for DNA manipulations
AU2014348224A1 (en) * 2013-11-18 2016-06-02 Takara Bio Usa, Inc. Degradable adaptors for background reduction
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
WO2015117040A1 (fr) * 2014-01-31 2015-08-06 Swift Biosciences, Inc. Procédés améliorés pour traiter des substats d'adn
WO2015134552A1 (fr) * 2014-03-03 2015-09-11 Swift Biosciences, Inc. Ligature d'adaptateur améliorée
JP6726659B2 (ja) 2014-04-10 2020-07-22 １０エックス ジェノミクス， インコーポレイテッド 試薬をカプセル化およびパーティション化するための流体デバイス、システム、および方法、ならびにそれらの応用
RU2723079C2 (ru) * 2014-04-22 2020-06-08 Инвайролоджикс, Инк. Композиции и способы для увеличения и/или прогнозирования амплификации днк
EP3919621A1 (fr) 2014-06-23 2021-12-08 The General Hospital Corporation Identification non biaisée, pangénomique, de dsb évaluée par séquençage (guide-seq)
US10839939B2 (en) 2014-06-26 2020-11-17 10X Genomics, Inc. Processes and systems for nucleic acid sequence assembly
US12312640B2 (en) 2014-06-26 2025-05-27 10X Genomics, Inc. Analysis of nucleic acid sequences
MX2016016902A (es) 2014-06-26 2017-03-27 10X Genomics Inc Metodos para analizar acidos nucleicos de celulas individuales o poblaciones de celulas.
AU2015279617A1 (en) 2014-06-26 2017-01-12 10X Genomics, Inc. Analysis of nucleic acid sequences
GB201413717D0 (en) 2014-08-01 2014-09-17 Olink Ab Method for selecting a target nucleic acid sequence
GB201413718D0 (en) * 2014-08-01 2014-09-17 Olink Ab Method for selecting a target nucleic acid sequence
EP3177740B1 (fr) 2014-08-06 2021-01-13 Nugen Technologies, Inc. Mesures numériques à partir de séquençage ciblé
GB201418621D0 (en) * 2014-10-20 2014-12-03 Cambridge Epigenetix Ltd Improved nucleic acid sample preparation using concatenation
CA2965137A1 (fr) 2014-10-20 2016-04-28 Envirologix, Inc. Compositions et procedes pour la detection d'un virus a arn
CA2964472A1 (fr) 2014-10-29 2016-05-06 10X Genomics, Inc. Procedes et compositions de sequencage cible d'acides nucleiques
EP3212808B1 (fr) 2014-10-30 2022-03-02 Personalis, Inc. Procédés d'utilisation du mosaïcisme dans des acides nucléiques prélevés de façon distale par rapport à leur origine
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
WO2016074701A1 (fr) 2014-11-10 2016-05-19 Gna Biosolutions Gmbh Procédé de multiplication d'acides nucléiques
JP2017537657A (ja) 2014-12-11 2017-12-21 ニユー・イングランド・バイオレイブス・インコーポレイテツド 標的配列の濃縮
WO2016114970A1 (fr) 2015-01-12 2016-07-21 10X Genomics, Inc. Procédés et systèmes de préparation de librairies de séquençage d'acide nucléique et librairies préparées au moyen de ceux-ci
CN107209814B (zh) 2015-01-13 2021-10-15 10X基因组学有限公司 用于使结构变异和相位信息可视化的系统和方法
EP3256606B1 (fr) 2015-02-09 2019-05-22 10X Genomics, Inc. Systèmes et procédés pour déterminer la variation structurale
JP2018505688A (ja) 2015-02-24 2018-03-01 １０エックス ゲノミクス，インコーポレイテッド 標的化核酸配列包括度（ｃｏｖｅｒａｇｅ）のための方法
EP4286516A3 (fr) 2015-02-24 2024-03-06 10X Genomics, Inc. Procédés et systèmes de traitement de cloisonnement
US10221448B2 (en) 2015-03-06 2019-03-05 Pillar Biosciences Inc. Selective amplification of overlapping amplicons
WO2016160965A1 (fr) 2015-03-30 2016-10-06 Rubicon Genomics, Inc. Procédés et compositions permettant la réparation des extrémités de l'adn par de multiples activités enzymatiques
US11274333B2 (en) 2015-05-29 2022-03-15 Molecular Cloning Laboratories (MCLAB) LLC Compositions and methods for preparing sequencing libraries
EP3307908B1 (fr) 2015-06-09 2019-09-11 Life Technologies Corporation Procédés pour le marquage moléculaire
US9476100B1 (en) 2015-07-06 2016-10-25 Nucleix Ltd. Methods for diagnosing bladder cancer
CN108350453A (zh) 2015-09-11 2018-07-31 通用医疗公司 核酸酶dsb的完全查询和测序(find-seq)
US9850484B2 (en) 2015-09-30 2017-12-26 The General Hospital Corporation Comprehensive in vitro reporting of cleavage events by sequencing (Circle-seq)
EP3371309B1 (fr) * 2015-11-04 2023-07-05 Atreca, Inc. Ensembles combinatoires de codes-barres d'acides nucléiques pour l'analyse d'acides nucléiques associés à des cellules uniques
JP6954899B2 (ja) 2015-12-04 2021-10-27 １０エックス ゲノミクス，インコーポレイテッド 核酸の解析のための方法及び組成物
WO2017138984A1 (fr) 2016-02-11 2017-08-17 10X Genomics, Inc. Systèmes, procédés, et milieux destinés à l'assemblage de novo de données de séquence du génome entier
WO2017197343A2 (fr) 2016-05-12 2017-11-16 10X Genomics, Inc. Filtres microfluidiques sur puce
WO2017197338A1 (fr) 2016-05-13 2017-11-16 10X Genomics, Inc. Systèmes microfluidiques et procédés d'utilisation
KR102806552B1 (ko) 2016-05-17 2025-05-13 디네임-아이티 엔브이 시료의 식별 방법
EP3246412A1 (fr) 2016-05-17 2017-11-22 DName-iT NV Procédés d'identification d'échantillons
EP3910068B1 (fr) 2016-05-24 2026-01-28 The Translational Genomics Research Institute Procédés de marquage moléculaire et bibliothèques de séquençage
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
WO2017218293A1 (fr) * 2016-06-16 2017-12-21 Richard Edward Watts Synthèse combinatoire dirigée et enregistrée d'oligonucléotides de molécules de sondes codées
US10370701B2 (en) 2016-06-17 2019-08-06 Pacific Biosciences Of California, Inc. Methods and compositions for generating asymmetrically-tagged nucleic acid fragments
ES2870639T3 (es) 2016-10-24 2021-10-27 Geneinfosec Inc Ocultación de información presente en los ácidos nucleicos
WO2018077847A1 (fr) * 2016-10-31 2018-05-03 F. Hoffmann-La Roche Ag Construction de bibliothèque circulaire à code-barres pour l'identification de produits chimériques
US20180142938A1 (en) * 2016-11-23 2018-05-24 Bsh Hausgeraete Gmbh Home Appliance Device
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US12264411B2 (en) 2017-01-30 2025-04-01 10X Genomics, Inc. Methods and systems for analysis
EP4628582A3 (fr) 2017-01-30 2025-12-24 10X Genomics, Inc. Procédés et systèmes de codage à barres de cellules uniques à base de gouttelettes
WO2018204420A1 (fr) * 2017-05-02 2018-11-08 Haystack Sciences Corporation Molécules de vérification de synthèse combinatoire dirigée par oligonucléotides et procédés de fabrication et d'utilisation associés
WO2018213774A1 (fr) 2017-05-19 2018-11-22 10X Genomics, Inc. Systèmes et procédés d'analyse d'ensembles de données
US20180340169A1 (en) 2017-05-26 2018-11-29 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
EP3445876B1 (fr) 2017-05-26 2023-07-05 10X Genomics, Inc. Analyse de la chromatine accessible par une transposase d'une cellule unique
WO2018235109A1 (fr) * 2017-06-20 2018-12-27 Ulisse Biomed S.R.L. Procédés d'empreinte moléculaire pour détecter et génotyper des cibles d'adn par réaction en chaîne par polymérase
CN118530967A (zh) 2017-08-23 2024-08-23 通用医疗公司 具有改变的PAM特异性的工程化的CRISPR-Cas9核酸酶
WO2019075197A1 (fr) 2017-10-11 2019-04-18 The General Hospital Corporation Procédés de détection de désamination génomique parasite et spécifique de site induite par des technologies d'édition de base
EP3954782A1 (fr) 2017-11-15 2022-02-16 10X Genomics, Inc. Perles de gel fonctionnalisées
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
WO2019024341A1 (fr) * 2017-11-27 2019-02-07 深圳华大生命科学研究院 Procédé de construction d'une bibliothèque d'adn acellulaire dans des liquides corporels et application associée
EP3775271B1 (fr) 2018-04-06 2025-03-12 10X Genomics, Inc. Systèmes et procédés de contrôle de qualité dans un traitement de cellules uniques
JP7460539B2 (ja) 2018-04-17 2024-04-02 ザ ジェネラル ホスピタル コーポレイション 核酸を結合、修飾、および切断する物質の基質選択性および部位のためのｉｎ ｖｉｔｒｏでの高感度アッセイ
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
JP7537748B2 (ja) 2018-06-06 2024-08-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 核酸ライブラリを生成する方法ならびにそれを実施するための組成物およびキット
ES2987423T3 (es) * 2018-07-24 2024-11-14 Salish Bioscience Inc Procedimientos y composición para un análisis genómico dirigido
IL265451B (en) 2019-03-18 2020-01-30 Frumkin Dan Methods and systems for the detection of methylation changes in DNA samples
US20220356467A1 (en) * 2019-06-25 2022-11-10 Board Of Regents, The University Of Texas System Methods for duplex sequencing of cell-free dna and applications thereof
EP3997242A4 (fr) * 2019-07-09 2023-08-02 The Translational Genomics Research Institute Méthodes de détection de maladie et de réponse au traitement de cfadn
CN114127284B (zh) * 2019-07-25 2024-07-26 华大青兰生物科技(无锡)有限公司 操纵双链dna末端的方法
US20230220377A1 (en) * 2019-07-31 2023-07-13 BioSkryb Genomics, Inc. Single cell analysis
US11427874B1 (en) 2019-08-26 2022-08-30 Epi One Inc. Methods and systems for detection of prostate cancer by DNA methylation analysis
JP7470787B2 (ja) 2019-11-05 2024-04-18 パーソナリス，インコーポレイティド 単一試料からの腫瘍純度の推定
KR102279846B1 (ko) 2019-12-26 2021-07-21 이원다이애그노믹스(주) 이중 가닥 핵산 분자 및 이를 이용한 dna 라이브러리 내 유리 어댑터 제거 방법
WO2021163630A1 (fr) 2020-02-13 2021-08-19 10X Genomics, Inc. Systèmes et procédés de visualisation interactive conjointe de l'expression génique et de l'accessibilité à la chromatine d'adn
JP7802295B2 (ja) * 2020-06-09 2026-01-20 イルミナ インコーポレイテッド シークエンシングライブラリーの収率を増加させるための方法
WO2021252617A1 (fr) * 2020-06-09 2021-12-16 Illumina, Inc. Procédés pour augmenter le rendement de bibliothèques de séquençage
EP4413580A4 (fr) 2021-10-05 2025-08-13 Personalis Inc Essais personnalisés pour la surveillance personnalisée d'un cancer
WO2023096650A1 (fr) * 2021-11-26 2023-06-01 National Health Research Institutes Procédé de terminaison d'un adn double brin par au moins une tige-boucle et kit associé
CN113862339B (zh) * 2021-12-01 2022-03-22 广州滴纳生物科技有限公司 核酸组合产品、检测试剂盒和扩增靶核酸的方法
WO2023172934A1 (fr) * 2022-03-09 2023-09-14 New England Biolabs, Inc. Enrichissement de cible
TW202403051A (zh) * 2022-07-01 2024-01-16 邱國平 直接由一滴未經純化的樣本擴增游離核酸之方法
WO2024073034A1 (fr) 2022-09-29 2024-04-04 The Board Of Trustees Of The Leland Stanford Junior University Préparation de banque de séquençage simplifiée pour adn
WO2024197081A1 (fr) 2023-03-20 2024-09-26 Hc Bioscience, Inc. Fils d'adn de taille minimale pour thérapie par arnt
WO2024200193A1 (fr) * 2023-03-31 2024-10-03 F. Hoffmann-La Roche Ag Procédés et compositions pour la préparation et l'analyse d'une banque d'adn
WO2024254224A2 (fr) * 2023-06-08 2024-12-12 Biomarin Pharmaceutical Inc. Procédés analytiques pour génomes de vecteurs de virus adéno-associés et leurs utilisations

Citations (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US667712A (en) * 1900-05-02 1901-02-12 Hermann A Klemm Take-up for sewing-machines.
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5104792A (en) * 1989-12-21 1992-04-14 The United States Of America As Represented By The Department Of Health And Human Services Method for amplifying unknown nucleic acid sequences
US5106727A (en) * 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
US5405760A (en) * 1992-04-30 1995-04-11 New England Biolabs, Inc. Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA
US5470724A (en) * 1992-02-20 1995-11-28 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Boomerang DNA amplification
US5514545A (en) * 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
US5714318A (en) * 1992-06-02 1998-02-03 Boehringer Mannheim Gmbh Simultaneous sequencing of nucleic acids
US5731171A (en) * 1993-07-23 1998-03-24 Arch Development Corp. Sequence independent amplification of DNA
US5759822A (en) * 1995-01-27 1998-06-02 Clontech Laboratories, Inc. Method for suppressing DNA fragment amplification during PCR
US5759821A (en) * 1993-04-16 1998-06-02 F B Investments Pty Ltd Method of random amplification of polymorphic DNA
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
US5948649A (en) * 1994-11-12 1999-09-07 Biotec Laboratories Limited Method for identifying nucleic acid sequences from different biological sources through amplification of the same
US5968743A (en) * 1996-10-14 1999-10-19 Hitachi, Ltd. DNA sequencing method and reagents kit
US5994058A (en) * 1995-03-20 1999-11-30 Genome International Corporation Method for contiguous genome sequencing
US6045994A (en) * 1991-09-24 2000-04-04 Keygene N.V. Selective restriction fragment amplification: fingerprinting
US6060245A (en) * 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations
US6107023A (en) * 1988-06-17 2000-08-22 Genelabs Technologies, Inc. DNA amplification and subtraction techniques
US6114149A (en) * 1988-07-26 2000-09-05 Genelabs Technologies, Inc. Amplification of mixed sequence nucleic acid fragments
US6124120A (en) * 1997-10-08 2000-09-26 Yale University Multiple displacement amplification
US6214556B1 (en) * 1997-11-27 2001-04-10 Epigenomics Ag Method for producing complex DNA methylation fingerprints
US6261774B1 (en) * 1990-06-11 2001-07-17 Gilead Sciences, Inc. Truncation selex method
US20010021518A1 (en) * 1996-02-14 2001-09-13 Jaap Goudsmit Isolation and amplification of nucleic acid materials
US6300071B1 (en) * 1998-07-29 2001-10-09 Keygene N.V. Method for detecting nucleic acid methylation using AFLP™
US20010046669A1 (en) * 1999-02-24 2001-11-29 Mccobmie William R. Genetically filtered shotgun sequencing of complex eukaryotic genomes
US6365375B1 (en) * 1998-03-26 2002-04-02 Wolfgang Dietmaier Method of primer-extension preamplification PCR
US6379932B1 (en) * 2000-07-17 2002-04-30 Incyte Genomics, Inc. Single primer PCR amplification of RNA
US6383754B1 (en) * 1999-08-13 2002-05-07 Yale University Binary encoded sequence tags
US20020058250A1 (en) * 1997-03-21 2002-05-16 Marshall, Gerstein & Borun Extraction and utilisation of vntr alleles
US6451563B1 (en) * 1998-06-15 2002-09-17 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Method for making linear, covalently closed DNA constructs
US20020192769A1 (en) * 2001-05-07 2002-12-19 Han Oh Park Polymerase chain reaction of DNA of which base sequence is completely unidentified
US6498023B1 (en) * 1999-12-02 2002-12-24 Molecular Staging, Inc. Generation of single-strand circular DNA from linear self-annealing segments
US20030013671A1 (en) * 2001-05-08 2003-01-16 Junichi Mineno Genomic DNA library
US6509160B1 (en) * 1994-09-16 2003-01-21 Affymetric, Inc. Methods for analyzing nucleic acids using a type IIs restriction endonuclease
US6521428B1 (en) * 1999-04-21 2003-02-18 Genome Technologies, Llc Shot-gun sequencing and amplification without cloning
US6537757B1 (en) * 1997-03-05 2003-03-25 The Regents Of The University Of Michigan Nucleic acid sequencing and mapping
US20030064393A1 (en) * 2000-01-11 2003-04-03 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
US20030099997A1 (en) * 2001-10-24 2003-05-29 Bestor Timothy H. Method for gene identification based on differential DNA methylation
US6576448B2 (en) * 1998-09-18 2003-06-10 Molecular Staging, Inc. Methods for selectively isolating DNA using rolling circle amplification
US20030129602A1 (en) * 1999-02-05 2003-07-10 Huang Tim Hui-Ming High-throughput methods for detecting DNA methylation
US20030143599A1 (en) * 2001-11-13 2003-07-31 Rubicon Genomics Inc. DNA amplification and sequencing using DNA molecules generated by random fragmentation
US6621782B1 (en) * 1998-08-05 2003-09-16 Mitsubishi Denki Kabushiki Kaisha Optical disk, an optical disk device, and a method of managing defects in an optical disk
US20030186237A1 (en) * 2001-02-14 2003-10-02 Baylor College Of Medicine Methods and compositions of amplifying RNA
US6632611B2 (en) * 2001-07-20 2003-10-14 Affymetrix, Inc. Method of target enrichment and amplification
US6638722B2 (en) * 2001-06-13 2003-10-28 Invitrogen Corporation Method for rapid amplification of DNA
US20030232371A1 (en) * 2001-10-24 2003-12-18 Bestor Timothy H. Methods for detecting methylated promoters based on differential DNA methylation
US6692915B1 (en) * 1999-07-22 2004-02-17 Girish N. Nallur Sequencing a polynucleotide on a generic chip
US6692918B2 (en) * 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
US20040115616A1 (en) * 2001-09-27 2004-06-17 Holton Timothy Albert Stem-loop vector system
US6762022B2 (en) * 1997-03-05 2004-07-13 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
US6787308B2 (en) * 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
US20040209298A1 (en) * 2003-03-07 2004-10-21 Emmanuel Kamberov Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process
US20040209299A1 (en) * 2003-03-07 2004-10-21 Rubicon Genomics, Inc. In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
US6808888B2 (en) * 2000-01-13 2004-10-26 Primagen Holding B.V. Universal nucleic acid amplification system for nucleic acids in a sample
US6825010B2 (en) * 2001-04-16 2004-11-30 Applera Corporation Methods and compositions for nucleotide analysis
US20050202490A1 (en) * 2004-03-08 2005-09-15 Makarov Vladimir L. Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
US6974141B2 (en) * 2003-09-29 2005-12-13 Hyundai Mobis Co., Ltd. Steering knuckle assembly for steering apparatus in motor vehicle
US20060110745A1 (en) * 2004-05-07 2006-05-25 Kabushiki Kaisha Dnaform Method for amplifying nucleic acids
US20060166250A1 (en) * 2005-01-25 2006-07-27 Sydney Brenner Isothermal DNA amplification
US20060216724A1 (en) * 2004-07-30 2006-09-28 Affymetrix, Inc. Methods for normalized amplification of nucleic acids

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648211A (en) 1994-04-18 1997-07-15 Becton, Dickinson And Company Strand displacement amplification using thermophilic enzymes
FR2726277B1 (fr) * 1994-10-28 1996-12-27 Bio Merieux Oligonucleotide utilisable comme amorce dans une methode d'amplification basee sur une replication avec deplacement de brin
JPH08173164A (ja) 1994-12-22 1996-07-09 Hitachi Ltd Ｄｎａ調製法
EP0854935B1 (fr) 1996-07-16 2005-04-13 Periannan Senapathy Procede de sequencage contigu de genome
GB9620769D0 (en) 1996-10-04 1996-11-20 Brax Genomics Ltd Nucleic acid sequencing
GB0002310D0 (en) * 2000-02-01 2000-03-22 Solexa Ltd Polynucleotide sequencing
ATE213783T1 (de) 1998-09-18 2002-03-15 Micromet Ag Dns amplifizierung aus einzelnen zellen
EP1190092A2 (fr) * 1999-04-06 2002-03-27 Yale University Analyse d'adresses fixes de s quences tiquet es
AU6387000A (en) 1999-07-29 2001-02-19 Genzyme Corporation Serial analysis of genetic alterations
US6958225B2 (en) 1999-10-27 2005-10-25 Affymetrix, Inc. Complexity management of genomic DNA
AU2002213882A1 (en) 2000-09-08 2002-03-22 Biomerieux B.V.A. Attenuated hiv strains and use thereof
US6794141B2 (en) 2000-12-22 2004-09-21 Arcturus Bioscience, Inc. Nucleic acid amplification
US6893820B1 (en) 2001-01-31 2005-05-17 The Ohio State University Research Foundation Detection of methylated CpG rich sequences diagnostic for malignant cells
ATE361996T1 (de) 2001-03-09 2007-06-15 Nugen Technologies Inc Methoden und zusammensetzungen zur vervielfältigung von rna sequenzen
WO2002103054A1 (fr) 2001-05-02 2002-12-27 Rubicon Genomics Inc. Marche sur le genome par l'amplification selective de bibliotheque d'adn de translation de coupure et l'amplification a partir de melanges complexes de matrices
EP1275738A1 (fr) 2001-07-11 2003-01-15 Roche Diagnostics GmbH Procédé pour la synthèse aléatoire et l'amplification d'ADNc
US20040175715A1 (en) 2001-08-21 2004-09-09 Burgoyne Leigh A. Method and device for simultaneously molecularly cloning and polylocus profiling of genomes or genomes mixtures
WO2003025215A1 (fr) 2001-09-14 2003-03-27 The University Of Queensland Detection de methylation d'adn
JP2006500901A (ja) 2001-09-26 2006-01-12 エピジェンクス ファーマスーティカルズ、 インコーポレイテッド Ｄｎａメチル化変化のアッセイ
JP2005522224A (ja) 2002-04-12 2005-07-28 キュアレイターズ オブ ザ ユニバーシティー オブ ミズーリ Ｄｎａの高メチル化と遺伝子サイレンシングの両方をスクリーニングするためのｅｃｉｓｔマイクロアレイと、そのｅｃｉｓｔマイクロアレイを利用して遺伝子の発現、ｄｎａのメチル化、ヒストンのアセチル化を評価するための統合システム
US20070128620A1 (en) * 2005-07-15 2007-06-07 Applera Corporation Hot start reverse transcription by primer design

Patent Citations (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US667712A (en) * 1900-05-02 1901-02-12 Hermann A Klemm Take-up for sewing-machines.
US6107023A (en) * 1988-06-17 2000-08-22 Genelabs Technologies, Inc. DNA amplification and subtraction techniques
US6114149A (en) * 1988-07-26 2000-09-05 Genelabs Technologies, Inc. Amplification of mixed sequence nucleic acid fragments
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
US5106727A (en) * 1989-04-27 1992-04-21 Life Technologies, Inc. Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers
US5104792A (en) * 1989-12-21 1992-04-14 The United States Of America As Represented By The Department Of Health And Human Services Method for amplifying unknown nucleic acid sequences
US6261774B1 (en) * 1990-06-11 2001-07-17 Gilead Sciences, Inc. Truncation selex method
US6045994A (en) * 1991-09-24 2000-04-04 Keygene N.V. Selective restriction fragment amplification: fingerprinting
US5470724A (en) * 1992-02-20 1995-11-28 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Boomerang DNA amplification
US5405760A (en) * 1992-04-30 1995-04-11 New England Biolabs, Inc. Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA
US5714318A (en) * 1992-06-02 1998-02-03 Boehringer Mannheim Gmbh Simultaneous sequencing of nucleic acids
US5514545A (en) * 1992-06-11 1996-05-07 Trustees Of The University Of Pennsylvania Method for characterizing single cells based on RNA amplification for diagnostics and therapeutics
US5759821A (en) * 1993-04-16 1998-06-02 F B Investments Pty Ltd Method of random amplification of polymorphic DNA
US5731171A (en) * 1993-07-23 1998-03-24 Arch Development Corp. Sequence independent amplification of DNA
US6509160B1 (en) * 1994-09-16 2003-01-21 Affymetric, Inc. Methods for analyzing nucleic acids using a type IIs restriction endonuclease
US5948649A (en) * 1994-11-12 1999-09-07 Biotec Laboratories Limited Method for identifying nucleic acid sequences from different biological sources through amplification of the same
US5759822A (en) * 1995-01-27 1998-06-02 Clontech Laboratories, Inc. Method for suppressing DNA fragment amplification during PCR
US5994058A (en) * 1995-03-20 1999-11-30 Genome International Corporation Method for contiguous genome sequencing
US20010021518A1 (en) * 1996-02-14 2001-09-13 Jaap Goudsmit Isolation and amplification of nucleic acid materials
US5968743A (en) * 1996-10-14 1999-10-19 Hitachi, Ltd. DNA sequencing method and reagents kit
US6060245A (en) * 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations
US6762022B2 (en) * 1997-03-05 2004-07-13 The Regents Of The University Of Michigan Compositions and methods for analysis of nucleic acids
US6537757B1 (en) * 1997-03-05 2003-03-25 The Regents Of The University Of Michigan Nucleic acid sequencing and mapping
US20020058250A1 (en) * 1997-03-21 2002-05-16 Marshall, Gerstein & Borun Extraction and utilisation of vntr alleles
US6280949B1 (en) * 1997-10-08 2001-08-28 Yale University Multiple displacement amplification
US6124120A (en) * 1997-10-08 2000-09-26 Yale University Multiple displacement amplification
US20040063144A1 (en) * 1997-10-08 2004-04-01 Lizardi Paul M. Multiple displacement amplification
US5932451A (en) * 1997-11-19 1999-08-03 Incyte Pharmaceuticals, Inc. Method for unbiased mRNA amplification
US6214556B1 (en) * 1997-11-27 2001-04-10 Epigenomics Ag Method for producing complex DNA methylation fingerprints
US6365375B1 (en) * 1998-03-26 2002-04-02 Wolfgang Dietmaier Method of primer-extension preamplification PCR
US6451563B1 (en) * 1998-06-15 2002-09-17 Mologen Forschungs-, Entwicklungs- Und Vertriebs Gmbh Method for making linear, covalently closed DNA constructs
US6300071B1 (en) * 1998-07-29 2001-10-09 Keygene N.V. Method for detecting nucleic acid methylation using AFLP™
US6787308B2 (en) * 1998-07-30 2004-09-07 Solexa Ltd. Arrayed biomolecules and their use in sequencing
US6621782B1 (en) * 1998-08-05 2003-09-16 Mitsubishi Denki Kabushiki Kaisha Optical disk, an optical disk device, and a method of managing defects in an optical disk
US6576448B2 (en) * 1998-09-18 2003-06-10 Molecular Staging, Inc. Methods for selectively isolating DNA using rolling circle amplification
US20030129602A1 (en) * 1999-02-05 2003-07-10 Huang Tim Hui-Ming High-throughput methods for detecting DNA methylation
US6605432B1 (en) * 1999-02-05 2003-08-12 Curators Of The University Of Missouri High-throughput methods for detecting DNA methylation
US20010046669A1 (en) * 1999-02-24 2001-11-29 Mccobmie William R. Genetically filtered shotgun sequencing of complex eukaryotic genomes
US6521428B1 (en) * 1999-04-21 2003-02-18 Genome Technologies, Llc Shot-gun sequencing and amplification without cloning
US6692915B1 (en) * 1999-07-22 2004-02-17 Girish N. Nallur Sequencing a polynucleotide on a generic chip
US6383754B1 (en) * 1999-08-13 2002-05-07 Yale University Binary encoded sequence tags
US6773886B2 (en) * 1999-08-13 2004-08-10 Yale University Binary encoded sequence tags
US6692918B2 (en) * 1999-09-13 2004-02-17 Nugen Technologies, Inc. Methods and compositions for linear isothermal amplification of polynucleotide sequences
US6498023B1 (en) * 1999-12-02 2002-12-24 Molecular Staging, Inc. Generation of single-strand circular DNA from linear self-annealing segments
US20030064393A1 (en) * 2000-01-11 2003-04-03 Maxygen, Inc. Integrated systems and methods for diversity generation and screening
US6808888B2 (en) * 2000-01-13 2004-10-26 Primagen Holding B.V. Universal nucleic acid amplification system for nucleic acids in a sample
US6379932B1 (en) * 2000-07-17 2002-04-30 Incyte Genomics, Inc. Single primer PCR amplification of RNA
US20030165885A1 (en) * 2000-07-17 2003-09-04 Lyle Arnold Single primer PCR amplification of RNA
US20030186237A1 (en) * 2001-02-14 2003-10-02 Baylor College Of Medicine Methods and compositions of amplifying RNA
US6825010B2 (en) * 2001-04-16 2004-11-30 Applera Corporation Methods and compositions for nucleotide analysis
US20020192769A1 (en) * 2001-05-07 2002-12-19 Han Oh Park Polymerase chain reaction of DNA of which base sequence is completely unidentified
US20030013671A1 (en) * 2001-05-08 2003-01-16 Junichi Mineno Genomic DNA library
US6638722B2 (en) * 2001-06-13 2003-10-28 Invitrogen Corporation Method for rapid amplification of DNA
US20040043416A1 (en) * 2001-06-13 2004-03-04 Invitrogen Corporation Method for rapid amplification of DNA
US6632611B2 (en) * 2001-07-20 2003-10-14 Affymetrix, Inc. Method of target enrichment and amplification
US20040115616A1 (en) * 2001-09-27 2004-06-17 Holton Timothy Albert Stem-loop vector system
US20030099997A1 (en) * 2001-10-24 2003-05-29 Bestor Timothy H. Method for gene identification based on differential DNA methylation
US20030232371A1 (en) * 2001-10-24 2003-12-18 Bestor Timothy H. Methods for detecting methylated promoters based on differential DNA methylation
US20030143599A1 (en) * 2001-11-13 2003-07-31 Rubicon Genomics Inc. DNA amplification and sequencing using DNA molecules generated by random fragmentation
US20040209299A1 (en) * 2003-03-07 2004-10-21 Rubicon Genomics, Inc. In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
US20040209298A1 (en) * 2003-03-07 2004-10-21 Emmanuel Kamberov Amplification and analysis of whole genome and whole transcriptome libraries generated by a DNA polymerization process
US6974141B2 (en) * 2003-09-29 2005-12-13 Hyundai Mobis Co., Ltd. Steering knuckle assembly for steering apparatus in motor vehicle
US20050202490A1 (en) * 2004-03-08 2005-09-15 Makarov Vladimir L. Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
US20060110745A1 (en) * 2004-05-07 2006-05-25 Kabushiki Kaisha Dnaform Method for amplifying nucleic acids
US20060216724A1 (en) * 2004-07-30 2006-09-28 Affymetrix, Inc. Methods for normalized amplification of nucleic acids
US20060166250A1 (en) * 2005-01-25 2006-07-27 Sydney Brenner Isothermal DNA amplification

Cited By (240)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060166250A1 (en) * 2005-01-25 2006-07-27 Sydney Brenner Isothermal DNA amplification
US20100015666A1 (en) * 2005-01-25 2010-01-21 Sydney Brenner Isothermal dna amplification
US7579153B2 (en) * 2005-01-25 2009-08-25 Population Genetics Technologies, Ltd. Isothermal DNA amplification
US12509728B2 (en) 2005-07-29 2025-12-30 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US12065703B2 (en) 2005-07-29 2024-08-20 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US10711309B2 (en) 2005-11-26 2020-07-14 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US11306359B2 (en) 2005-11-26 2022-04-19 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US7368265B2 (en) * 2006-01-23 2008-05-06 Compass Genetics, Llc Selective genome amplification
US20070190556A1 (en) * 2006-01-23 2007-08-16 Sydney Brenner Selective genome amplification
US9562263B2 (en) 2007-07-14 2017-02-07 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US9617586B2 (en) 2007-07-14 2017-04-11 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US9689031B2 (en) 2007-07-14 2017-06-27 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US10851406B2 (en) 2007-07-14 2020-12-01 Ionian Technologies, Llc Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US9562264B2 (en) 2007-07-14 2017-02-07 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US20090081670A1 (en) * 2007-07-14 2009-03-26 Ionian Technologies, Inc. Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US20090017453A1 (en) * 2007-07-14 2009-01-15 Maples Brian K Nicking and extension amplification reaction for the exponential amplification of nucleic acids
US8278051B2 (en) 2007-10-11 2012-10-02 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
US8003322B2 (en) * 2007-10-11 2011-08-23 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
US20090098612A1 (en) * 2007-10-11 2009-04-16 Samsung Electronics Co., Ltd. Method of amplifying a target nucleic acid by rolling circle amplification
JP2009225682A (ja) * 2008-03-19 2009-10-08 National Institute Of Agrobiological Sciences 外来ｄｎａ断片由来の逆方向反復配列を含む組換えベクター及びその作製方法
US20140030704A1 (en) * 2008-04-30 2014-01-30 Population Genetics Technologies Ltd Asymmetric Adapter Library Construction
US8883990B2 (en) * 2008-04-30 2014-11-11 New England Biolabs, Inc. Asymmetric adapter library construction
WO2010030683A1 (fr) * 2008-09-09 2010-03-18 Rosetta Inpharmatics Llc Procédés de génération de bibliothèques spécifiques de gènes
US11352664B2 (en) 2009-01-30 2022-06-07 Oxford Nanopore Technologies Plc Adaptors for nucleic acid constructs in transmembrane sequencing
US11459606B2 (en) 2009-01-30 2022-10-04 Oxford Nanopore Technologies Plc Adaptors for nucleic acid constructs in transmembrane sequencing
US20110105364A1 (en) * 2009-11-02 2011-05-05 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence selection and amplification
US20130045885A1 (en) * 2010-02-18 2013-02-21 Univeristy Of South Florida Materials and methods for profiling micrornas
US10793912B2 (en) 2010-05-18 2020-10-06 Natera, Inc. Methods for simultaneous amplification of target loci
US12494267B2 (en) 2010-05-18 2025-12-09 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11519035B2 (en) 2010-05-18 2022-12-06 Natera, Inc. Methods for simultaneous amplification of target loci
US11111545B2 (en) 2010-05-18 2021-09-07 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11482300B2 (en) 2010-05-18 2022-10-25 Natera, Inc. Methods for preparing a DNA fraction from a biological sample for analyzing genotypes of cell-free DNA
US12410476B2 (en) 2010-05-18 2025-09-09 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12270073B2 (en) 2010-05-18 2025-04-08 Natera, Inc. Methods for preparing a biological sample obtained from an individual for use in a genetic testing assay
US11525162B2 (en) 2010-05-18 2022-12-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US12020778B2 (en) 2010-05-18 2024-06-25 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11286530B2 (en) 2010-05-18 2022-03-29 Natera, Inc. Methods for simultaneous amplification of target loci
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11312996B2 (en) 2010-05-18 2022-04-26 Natera, Inc. Methods for simultaneous amplification of target loci
US10774380B2 (en) 2010-05-18 2020-09-15 Natera, Inc. Methods for multiplex PCR amplification of target loci in a nucleic acid sample
US10731220B2 (en) 2010-05-18 2020-08-04 Natera, Inc. Methods for simultaneous amplification of target loci
US11746376B2 (en) 2010-05-18 2023-09-05 Natera, Inc. Methods for amplification of cell-free DNA using ligated adaptors and universal and inner target-specific primers for multiplexed nested PCR
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12110552B2 (en) 2010-05-18 2024-10-08 Natera, Inc. Methods for simultaneous amplification of target loci
US12509730B2 (en) 2010-05-18 2025-12-30 Natera, Inc. Methods for simultaneous amplification of target loci
US11306357B2 (en) 2010-05-18 2022-04-19 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20110319290A1 (en) * 2010-06-08 2011-12-29 Nugen Technologies, Inc. Methods and Compositions for Multiplex Sequencing
US12234510B2 (en) * 2010-10-22 2025-02-25 Cold Spring Harbor Laboratory Varietal counting of nucleic acids for obtaining genomic copy number information
US20190153535A1 (en) * 2010-10-22 2019-05-23 Cold Spring Harbor Laboratory Varietal counting of nucleic acids for obtaining genomic copy number information
US10233443B2 (en) 2010-11-03 2019-03-19 Illumina, Inc. Reducing adapter dimer formation
WO2012061036A1 (fr) * 2010-11-03 2012-05-10 Illumina, Inc. Réduction de la formation de dimères adaptères
US8575071B2 (en) 2010-11-03 2013-11-05 Illumina, Inc. Reducing adapter dimer formation
US9506055B2 (en) 2010-11-03 2016-11-29 Illumina, Inc. Reducing adapter dimer formation
US9109222B2 (en) * 2010-12-27 2015-08-18 Ibis Biosciences, Inc. Nucleic acid sample preparation methods and compositions
US9493825B2 (en) 2011-03-18 2016-11-15 University Of South Florida Materials and methods for profiling microRNAs
US20140256568A1 (en) * 2011-06-02 2014-09-11 Raindance Technologies, Inc. Sample multiplexing
US9376711B2 (en) 2011-07-13 2016-06-28 Qiagen Mansfield, Inc. Multimodal methods for simultaneous detection and quantification of multiple nucleic acids in a sample
US11168363B2 (en) 2011-07-25 2021-11-09 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US11261487B2 (en) 2011-07-25 2022-03-01 Oxford Nanopore Technologies Plc Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US12168799B2 (en) 2011-07-25 2024-12-17 Oxford Nanopore Technologies Plc Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US10597713B2 (en) 2011-07-25 2020-03-24 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US10851409B2 (en) 2011-07-25 2020-12-01 Oxford Nanopore Technologies Ltd. Hairpin loop method for double strand polynucleotide sequencing using transmembrane pores
US11702662B2 (en) * 2011-08-26 2023-07-18 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
US9109226B2 (en) * 2011-09-01 2015-08-18 New England Biolabs, Inc. Synthetic nucleic acids for polymerization reactions
US20130230887A1 (en) * 2011-09-01 2013-09-05 New England Biolabs, Inc. Synthetic Nucleic Acids for Polymerization Reactions
US12269026B2 (en) 2011-09-23 2025-04-08 Abbott Diagnostics Scarborough, Inc. System and apparatus for reactions including a liquid transfer device with an asymmetrical cross-section
US10040061B2 (en) 2011-09-23 2018-08-07 Alere Switzerland Gmbh System and apparatus for reactions
US9352312B2 (en) 2011-09-23 2016-05-31 Alere Switzerland Gmbh System and apparatus for reactions
US11033894B2 (en) 2011-09-23 2021-06-15 Abbott Diagnostics Scarborough, Inc. System and apparatus for reactions
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
US10876160B2 (en) * 2011-10-31 2020-12-29 Eiken Kagaku Kabushiki Kaisha Method for detecting target nucleic acid
US9650628B2 (en) 2012-01-26 2017-05-16 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library regeneration
US10876108B2 (en) 2012-01-26 2020-12-29 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
US10036012B2 (en) 2012-01-26 2018-07-31 Nugen Technologies, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
US10640818B2 (en) 2012-01-31 2020-05-05 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
US20140134610A1 (en) * 2012-01-31 2014-05-15 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
US9528107B2 (en) * 2012-01-31 2016-12-27 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
US9957549B2 (en) 2012-06-18 2018-05-01 Nugen Technologies, Inc. Compositions and methods for negative selection of non-desired nucleic acid sequences
US11697843B2 (en) 2012-07-09 2023-07-11 Tecan Genomics, Inc. Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US11028430B2 (en) 2012-07-09 2021-06-08 Nugen Technologies, Inc. Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
US11155860B2 (en) 2012-07-19 2021-10-26 Oxford Nanopore Technologies Ltd. SSB method
US12448646B2 (en) 2012-07-19 2025-10-21 Oxford Nanopore Technologies Plc SSB method
US12100478B2 (en) 2012-08-17 2024-09-24 Natera, Inc. Method for non-invasive prenatal testing using parental mosaicism data
US11149303B2 (en) * 2012-09-13 2021-10-19 Takara Bio Usa, Inc. Methods of depleting a target nucleic acid in a sample and kits for practicing the same
US11584959B2 (en) 2012-11-01 2023-02-21 Pacific Biosciences Of California, Inc. Compositions and methods for selection of nucleic acids
US11208688B2 (en) 2012-11-02 2021-12-28 Life Technologies Corporation Small RNA capture, detection and quantification
US10954553B2 (en) 2012-11-02 2021-03-23 Life Technologies Corporation Compositions, methods and kits for enhancing PCR specificity
US9416405B2 (en) 2012-11-02 2016-08-16 Life Technologies Corporation Compositions, methods and kits for enhancing PCR specificity
US9920360B2 (en) * 2012-11-02 2018-03-20 Life Technologies Corporation Small RNA capture, detection and quantification
US20150105275A1 (en) * 2012-11-02 2015-04-16 Life Technologies Corporation Small RNA Capture, Detection and Quantification
US11473132B2 (en) 2012-11-02 2022-10-18 Life Technologies Corporation Compositions, methods and kits for enhancing PCR specificity
US20210189382A1 (en) * 2012-11-05 2021-06-24 Takara Bio Usa, Inc. Barcoding Nucleic Acids
JP2022031278A (ja) * 2013-02-20 2022-02-18 エモリー ユニバーシティー 混合物中の核酸を配列決定する方法およびそれに関する組成物
US11203750B2 (en) 2013-02-20 2021-12-21 Emory University Methods of sequencing nucleic acids in mixtures and compositions related thereto
JP2016507246A (ja) * 2013-02-20 2016-03-10 エモリー ユニバーシティー 混合物中の核酸を配列決定する方法およびそれに関する組成物
EP2959019A4 (fr) * 2013-02-20 2016-11-02 Univ Emory Méthodes de séquençage d'acides nucléiques présents dans des mélanges et compositions associées
US10227584B2 (en) * 2013-02-20 2019-03-12 Emory University Methods of sequencing nucleic acids in mixtures and compositions related thereto
CN105121664A (zh) * 2013-02-20 2015-12-02 埃默里大学 混合物及其相关组合物中的核酸的测序方法
JP7290228B2 (ja) 2013-02-20 2023-06-13 エモリー ユニバーシティー 混合物中の核酸を配列決定する方法およびそれに関する組成物
US11560589B2 (en) 2013-03-08 2023-01-24 Oxford Nanopore Technologies Plc Enzyme stalling method
WO2014160059A1 (fr) * 2013-03-13 2014-10-02 Gen9, Inc. Compositions et procédés pour la synthèse d'oligonucléotides à fidélité élevée
US10053719B2 (en) 2013-03-13 2018-08-21 Gen9, Inc. Compositions and methods for synthesis of high fidelity oligonucleotides
US9822408B2 (en) 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
US10450595B2 (en) 2013-03-15 2019-10-22 Theranos Ip Company, Llc Nucleic acid amplification
US11254960B2 (en) 2013-03-15 2022-02-22 Labrador Diagnostics Llc Nucleic acid amplification
US11649487B2 (en) 2013-03-15 2023-05-16 Labrador Diagnostics Llc Nucleic acid amplification
US10131939B2 (en) 2013-03-15 2018-11-20 Theranos Ip Company, Llc Nucleic acid amplification
US10619206B2 (en) 2013-03-15 2020-04-14 Tecan Genomics Sequential sequencing
US10017809B2 (en) 2013-03-15 2018-07-10 Theranos Ip Company, Llc Nucleic acid amplification
US11603558B2 (en) 2013-03-15 2023-03-14 Labrador Diagnostics Llc Nucleic acid amplification
US10745745B2 (en) 2013-03-15 2020-08-18 Labrador Diagnostics Llc Nucleic acid amplification
US10760123B2 (en) 2013-03-15 2020-09-01 Nugen Technologies, Inc. Sequential sequencing
US11559778B2 (en) 2013-08-05 2023-01-24 Twist Bioscience Corporation De novo synthesized gene libraries
US9403141B2 (en) 2013-08-05 2016-08-02 Twist Bioscience Corporation De novo synthesized gene libraries
US10632445B2 (en) 2013-08-05 2020-04-28 Twist Bioscience Corporation De novo synthesized gene libraries
US10618024B2 (en) 2013-08-05 2020-04-14 Twist Bioscience Corporation De novo synthesized gene libraries
US9555388B2 (en) 2013-08-05 2017-01-31 Twist Bioscience Corporation De novo synthesized gene libraries
US9889423B2 (en) 2013-08-05 2018-02-13 Twist Bioscience Corporation De novo synthesized gene libraries
US10272410B2 (en) 2013-08-05 2019-04-30 Twist Bioscience Corporation De novo synthesized gene libraries
US10384188B2 (en) 2013-08-05 2019-08-20 Twist Bioscience Corporation De novo synthesized gene libraries
US9409139B2 (en) 2013-08-05 2016-08-09 Twist Bioscience Corporation De novo synthesized gene libraries
US10773232B2 (en) 2013-08-05 2020-09-15 Twist Bioscience Corporation De novo synthesized gene libraries
US11185837B2 (en) 2013-08-05 2021-11-30 Twist Bioscience Corporation De novo synthesized gene libraries
US9839894B2 (en) 2013-08-05 2017-12-12 Twist Bioscience Corporation De novo synthesized gene libraries
US10583415B2 (en) 2013-08-05 2020-03-10 Twist Bioscience Corporation De novo synthesized gene libraries
US10639609B2 (en) 2013-08-05 2020-05-05 Twist Bioscience Corporation De novo synthesized gene libraries
US9833761B2 (en) 2013-08-05 2017-12-05 Twist Bioscience Corporation De novo synthesized gene libraries
US11452980B2 (en) 2013-08-05 2022-09-27 Twist Bioscience Corporation De novo synthesized gene libraries
US10501767B2 (en) 2013-08-16 2019-12-10 Oxford Nanopore Technologies Ltd. Polynucleotide modification methods
US11186857B2 (en) 2013-08-16 2021-11-30 Oxford Nanopore Technologies Plc Polynucleotide modification methods
US9428798B2 (en) * 2013-09-16 2016-08-30 Samsung Electronics Co., Ltd Polynucleotide and use thereof
KR102124058B1 (ko) * 2013-09-16 2020-06-17 삼성전자주식회사 폴리뉴클레오티드 및 그의 용도
KR20150031687A (ko) * 2013-09-16 2015-03-25 삼성전자주식회사 폴리뉴클레오티드 및 그의 용도
US20150080241A1 (en) * 2013-09-16 2015-03-19 Samsung Electronics Co., Ltd. Polynucleotide and use thereof
US10570448B2 (en) 2013-11-13 2020-02-25 Tecan Genomics Compositions and methods for identification of a duplicate sequencing read
US11098357B2 (en) 2013-11-13 2021-08-24 Tecan Genomics, Inc. Compositions and methods for identification of a duplicate sequencing read
US11725241B2 (en) 2013-11-13 2023-08-15 Tecan Genomics, Inc. Compositions and methods for identification of a duplicate sequencing read
US11542551B2 (en) 2014-02-21 2023-01-03 Oxford Nanopore Technologies Plc Sample preparation method
US10669578B2 (en) 2014-02-21 2020-06-02 Oxford Nanopore Technologies Ltd. Sample preparation method
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
US11371100B2 (en) 2014-04-21 2022-06-28 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US12492429B2 (en) 2014-04-21 2025-12-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11319595B2 (en) 2014-04-21 2022-05-03 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11319596B2 (en) 2014-04-21 2022-05-03 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11486008B2 (en) 2014-04-21 2022-11-01 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11530454B2 (en) 2014-04-21 2022-12-20 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11390916B2 (en) 2014-04-21 2022-07-19 Natera, Inc. Methods for simultaneous amplification of target loci
US12486542B2 (en) 2014-04-21 2025-12-02 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11408037B2 (en) 2014-04-21 2022-08-09 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US12203142B2 (en) 2014-04-21 2025-01-21 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US11414709B2 (en) 2014-04-21 2022-08-16 Natera, Inc. Detecting mutations and ploidy in chromosomal segments
US12305229B2 (en) 2014-04-21 2025-05-20 Natera, Inc. Methods for simultaneous amplification of target loci
US12260934B2 (en) 2014-06-05 2025-03-25 Natera, Inc. Systems and methods for detection of aneuploidy
EP3161157B1 (fr) * 2014-06-24 2024-03-27 Bio-Rad Laboratories, Inc. "barcoding" par pcr numérique
CN105392902A (zh) * 2014-06-24 2016-03-09 生物辐射实验室股份有限公司 数字式pcr条码化
US11155809B2 (en) 2014-06-24 2021-10-26 Bio-Rad Laboratories, Inc. Digital PCR barcoding
WO2015200541A1 (fr) 2014-06-24 2015-12-30 Bio-Rad Laboratories, Inc. "barcoding" par pcr numérique
US20170240955A1 (en) * 2014-10-14 2017-08-24 Oxford Nanopore Technologies Ltd. Method
US10570440B2 (en) * 2014-10-14 2020-02-25 Oxford Nanopore Technologies Ltd. Method for modifying a template double stranded polynucleotide using a MuA transposase
US11390904B2 (en) 2014-10-14 2022-07-19 Oxford Nanopore Technologies Plc Nanopore-based method and double stranded nucleic acid construct therefor
JP2017530714A (ja) * 2014-10-14 2017-10-19 オックスフォード ナノポール テクノロジーズ リミテッド 方法
US11697668B2 (en) 2015-02-04 2023-07-11 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
US9677067B2 (en) 2015-02-04 2017-06-13 Twist Bioscience Corporation Compositions and methods for synthetic gene assembly
US10669304B2 (en) 2015-02-04 2020-06-02 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
US11274340B2 (en) 2015-03-13 2022-03-15 Life Technologies Corporation Methods, compositions and kits for small RNA capture, detection and quantification
US10563250B2 (en) 2015-03-13 2020-02-18 Life Technologies Corporation Methods, compositions and kits for small RNA capture, detection and quantification
US11691118B2 (en) 2015-04-21 2023-07-04 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
US9981239B2 (en) 2015-04-21 2018-05-29 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
US10744477B2 (en) 2015-04-21 2020-08-18 Twist Bioscience Corporation Devices and methods for oligonucleic acid library synthesis
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
US11946101B2 (en) 2015-05-11 2024-04-02 Natera, Inc. Methods and compositions for determining ploidy
WO2016195963A1 (fr) * 2015-05-29 2016-12-08 Tsavachidou Dimitra Procédés de construction de copies de molécules d'acide nucléique reliées de façon consécutive
US20180208966A1 (en) * 2015-07-17 2018-07-26 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Cloning of single-stranded nucleic acid
US10894980B2 (en) * 2015-07-17 2021-01-19 President And Fellows Of Harvard College Methods of amplifying nucleic acid sequences mediated by transposase/transposon DNA complexes
CN108138209A (zh) * 2015-08-12 2018-06-08 环基因治疗诊断有限责任公司 通过原位扩增制备细胞游离核酸分子的方法
US11807956B2 (en) 2015-09-18 2023-11-07 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
US10844373B2 (en) 2015-09-18 2020-11-24 Twist Bioscience Corporation Oligonucleic acid variant libraries and synthesis thereof
US11512347B2 (en) 2015-09-22 2022-11-29 Twist Bioscience Corporation Flexible substrates for nucleic acid synthesis
US10384189B2 (en) 2015-12-01 2019-08-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
US9895673B2 (en) 2015-12-01 2018-02-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
US10987648B2 (en) 2015-12-01 2021-04-27 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
US12146195B2 (en) 2016-04-15 2024-11-19 Natera, Inc. Methods for lung cancer detection
US11649480B2 (en) 2016-05-25 2023-05-16 Oxford Nanopore Technologies Plc Method for modifying a template double stranded polynucleotide
US10975372B2 (en) 2016-08-22 2021-04-13 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
US10053688B2 (en) 2016-08-22 2018-08-21 Twist Bioscience Corporation De novo synthesized nucleic acid libraries
US11562103B2 (en) 2016-09-21 2023-01-24 Twist Bioscience Corporation Nucleic acid based data storage
US10754994B2 (en) 2016-09-21 2020-08-25 Twist Bioscience Corporation Nucleic acid based data storage
US11263354B2 (en) 2016-09-21 2022-03-01 Twist Bioscience Corporation Nucleic acid based data storage
US10417457B2 (en) 2016-09-21 2019-09-17 Twist Bioscience Corporation Nucleic acid based data storage
US12056264B2 (en) 2016-09-21 2024-08-06 Twist Bioscience Corporation Nucleic acid based data storage
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US12460264B2 (en) 2016-11-02 2025-11-04 Natera, Inc. Method of detecting tumour recurrence
US11519028B2 (en) 2016-12-07 2022-12-06 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US11530442B2 (en) 2016-12-07 2022-12-20 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
US20210340598A1 (en) * 2016-12-14 2021-11-04 Codex Dna, Inc. Methods for assembling dna molecules
US10907274B2 (en) 2016-12-16 2021-02-02 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
US11550939B2 (en) 2017-02-22 2023-01-10 Twist Bioscience Corporation Nucleic acid based data storage using enzymatic bioencryption
US10894959B2 (en) 2017-03-15 2021-01-19 Twist Bioscience Corporation Variant libraries of the immunological synapse and synthesis thereof
US12492430B2 (en) 2017-04-11 2025-12-09 Tecan Genomics, Inc. Library quantitation and qualification
US11377676B2 (en) 2017-06-12 2022-07-05 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US10696965B2 (en) 2017-06-12 2020-06-30 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US11332740B2 (en) 2017-06-12 2022-05-17 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US12270028B2 (en) 2017-06-12 2025-04-08 Twist Bioscience Corporation Methods for seamless nucleic acid assembly
US11667952B2 (en) 2017-08-24 2023-06-06 Takara Bio Usa, Inc. Methods of producing nucleic acids using oligonucleotides modified by a stimulus
US12203128B2 (en) 2017-08-24 2025-01-21 Takara Bio Usa, Inc. Methods of producing nucleic acids using oligonucleotides modified by a stimulus
US11407837B2 (en) 2017-09-11 2022-08-09 Twist Bioscience Corporation GPCR binding proteins and synthesis thereof
US11629377B2 (en) 2017-09-29 2023-04-18 Evonetix Ltd Error detection during hybridisation of target double-stranded nucleic acid
US10894242B2 (en) 2017-10-20 2021-01-19 Twist Bioscience Corporation Heated nanowells for polynucleotide synthesis
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
US11745159B2 (en) 2017-10-20 2023-09-05 Twist Bioscience Corporation Heated nanowells for polynucleotide synthesis
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US10936953B2 (en) 2018-01-04 2021-03-02 Twist Bioscience Corporation DNA-based digital information storage with sidewall electrodes
US12086722B2 (en) 2018-01-04 2024-09-10 Twist Bioscience Corporation DNA-based digital information storage with sidewall electrodes
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
US12385096B2 (en) 2018-04-14 2025-08-12 Natera, Inc. Methods for cancer detection and monitoring
US11725205B2 (en) 2018-05-14 2023-08-15 Oxford Nanopore Technologies Plc Methods and polynucleotides for amplifying a target polynucleotide
US11492665B2 (en) 2018-05-18 2022-11-08 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
US11732294B2 (en) 2018-05-18 2023-08-22 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
US12522868B2 (en) 2018-05-18 2026-01-13 Twist Bioscience Corporation Polynucleotides, reagents, and methods for nucleic acid hybridization
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
US20210198733A1 (en) 2018-07-03 2021-07-01 Natera, Inc. Methods for detection of donor-derived cell-free dna
CN110760579A (zh) * 2018-10-10 2020-02-07 杭州翱锐基因科技有限公司 扩增游离dna的试剂以及扩增方法
US12357959B2 (en) 2018-12-26 2025-07-15 Twist Bioscience Corporation Highly accurate de novo polynucleotide synthesis
US12331427B2 (en) 2019-02-26 2025-06-17 Twist Bioscience Corporation Antibodies that bind GLP1R
US11492728B2 (en) 2019-02-26 2022-11-08 Twist Bioscience Corporation Variant nucleic acid libraries for antibody optimization
US11492727B2 (en) 2019-02-26 2022-11-08 Twist Bioscience Corporation Variant nucleic acid libraries for GLP1 receptor
US12305235B2 (en) 2019-06-06 2025-05-20 Natera, Inc. Methods for detecting immune cell DNA and monitoring immune system
US11332738B2 (en) 2019-06-21 2022-05-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
US12173282B2 (en) 2019-09-23 2024-12-24 Twist Bioscience, Inc. Antibodies that bind CD3 epsilon
US12091777B2 (en) 2019-09-23 2024-09-17 Twist Bioscience Corporation Variant nucleic acid libraries for CRTH2
US12059674B2 (en) 2020-02-03 2024-08-13 Tecan Genomics, Inc. Reagent storage system

Also Published As

Publication number Publication date
US20150079637A1 (en) 2015-03-19
DK1924704T3 (da) 2011-09-05
US20130303407A1 (en) 2013-11-14
US20100021973A1 (en) 2010-01-28
US7803550B2 (en) 2010-09-28
EP1924704A1 (fr) 2008-05-28
US10208337B2 (en) 2019-02-19
US20120142060A1 (en) 2012-06-07
US20110081685A1 (en) 2011-04-07
US8399199B2 (en) 2013-03-19
US10196686B2 (en) 2019-02-05
ATE510930T1 (de) 2011-06-15
US20170342475A1 (en) 2017-11-30
WO2007018601A1 (fr) 2007-02-15
EP1924704B1 (fr) 2011-05-25
US8071312B2 (en) 2011-12-06
US20190119741A1 (en) 2019-04-25
US20170314069A1 (en) 2017-11-02
US8728737B2 (en) 2014-05-20
US11072823B2 (en) 2021-07-27
US20210292828A1 (en) 2021-09-23
US9598727B2 (en) 2017-03-21

Similar Documents

Publication Publication Date Title
US11072823B2 (en) Compositions including a double stranded nucleic acid molecule and a stem-loop oligonucleotide
DK2787565T3 (en) Transposon-end COMPOSITIONS AND METHODS TO MODIFY nucleic acids
US9080211B2 (en) Transposon end compositions and methods for modifying nucleic acids
HK1249765A1 (en) Transposon end compositions and methods for modifying nucleic acids
HK1197498B (en) Transposon end compositions and methods for modifying nucleic acids
HK1163107B (en) Transposon end compositions and methods for modifying nucleic acids
HK1169659B (en) Transposon end compositions and methods for modifying nucleic acids

Legal Events

Date Code Title Description
AS Assignment

Owner name: RUBICON GENOMICS, INC., MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MAKAROV, VLADIMIR L.;KAMBEROV, EMMANUEL;TARRIER, BRENDAN J.;REEL/FRAME:017666/0663

Effective date: 20060523

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: TAKARA BIO USA, INC., CALIFORNIA

Free format text: MERGER;ASSIGNOR:RUBICON GENOMICS, INC.;REEL/FRAME:043631/0549

Effective date: 20170331